WO2015051378A1 - Systèmes et procédés pour analyse fondée sur des nanopores d'acides nucléiques - Google Patents

Systèmes et procédés pour analyse fondée sur des nanopores d'acides nucléiques Download PDF

Info

Publication number
WO2015051378A1
WO2015051378A1 PCT/US2014/059360 US2014059360W WO2015051378A1 WO 2015051378 A1 WO2015051378 A1 WO 2015051378A1 US 2014059360 W US2014059360 W US 2014059360W WO 2015051378 A1 WO2015051378 A1 WO 2015051378A1
Authority
WO
WIPO (PCT)
Prior art keywords
nanopore
nucleic acid
current
dna
liquid medium
Prior art date
Application number
PCT/US2014/059360
Other languages
English (en)
Inventor
Jens Gundlach
Ian M. Derrington
Elizabeth A. MANRAO
Kyle W. Langford
Andrew Laszlo
Original Assignee
University Of Washington Through Its Center For Commercialization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Washington Through Its Center For Commercialization filed Critical University Of Washington Through Its Center For Commercialization
Publication of WO2015051378A1 publication Critical patent/WO2015051378A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores

Definitions

  • sequence listing associated with this application is provided in text format in lieu of a paper copy and is hereby incorporated by reference into the specification.
  • the name of the text file containing the sequence listing is 52613_SEQ_LISTING_ST25.txt.
  • the text file is 9 KB; was created on October 6, 2014; and is being submitted via EFS- Web with the filing of the specification.
  • Nanopore-based analysis methods have been investigated as an alternative to traditional polymer analysis approaches. These methods involve passing a polymeric molecule, for example single-stranded DNA ("ssDNA”), through a nanoscopic opening while monitoring a signal, such as an electrical signal, that is influenced by the physical properties of the polymer subunits as the polymer analyte passes through the nanopore opening.
  • a signal such as an electrical signal
  • the nanopore optimally has a size or three-dimensional configuration that allows the polymer to pass only in a sequential, single file order. Under theoretically optimal conditions, the polymer molecule passes through the nanopore at a rate such that the passage of each discrete monomeric subunit of the polymer can be correlated with the monitored signal.
  • Nanopores such as solid state nanopores and protein nanopores held within lipid bilayer membranes, have been heretofore used for analysis of DNA, RNA, and polypeptides and, thus, provide the potential advantage of robust analysis of polymers even at low copy number.
  • k-mer the number of nucleotides
  • the k-mer subsequence of the nucleic acid segment residing in the constriction zone shifts by a single nucleotide.
  • the series of consecutive measured current signals is determined by a corresponding series nucleic acid segments that have overlapping nucleotide subsequences.
  • the monitored signals must undergo a deconvolution analysis to deduce a correlation between the observed signal and the subsequence of the multiple nucleotides residing in the constriction zone that determined the particular signal.
  • This deconvolution from signal to sequence requires consideration that multiple k-mer subsequences often results in similar sequences and typically relies identifying the progressing cascade of possible k-mer subsequences that can result in a continuous sequence.
  • the disclosure provides a method for analyzing a nucleic acid.
  • the method comprises translocating the nucleic acid through a nanopore from a first conductive liquid medium to a second conductive liquid medium, wherein the nanopore comprises a constriction zone, and wherein the nanopore is disposed in a membrane and provides liquid communication between the first conductive liquid medium and the second conductive liquid medium.
  • the method also comprises applying a non-constant electrical potential between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid translocates through the nanopore.
  • the method also comprises measuring a plurality of current signals between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid translocates through the nanopore.
  • the method also comprises identifying a subset of the plurality of measured current signals associated with a single translocation step of the nucleic acid. Finally, the method also comprises deriving a current-potential curve from the subset of current signals to provide a current pattern. In some embodiments, the method also comprises determining a characteristic of the nucleic acid based on the current pattern.
  • the characteristic of the nucleic acid is the identity of one or more nucleotide residues of the nucleic acid.
  • the current-potential curve is indicative of the identity of the one or more nucleotide residues in the nucleic acid.
  • the method further comprises applying a compensatory electrical potential to substantially offset any current resulting from capacitance of the membrane, nucleic acid, or nanopore. In some embodiments, the method further comprises correcting the plurality of measured current signals, or the subset thereof, for any current not associated with passage of ions through the nanopore. In some embodiments, the current not associated with the passage of ions through the nanopore is current associated with the capacitance of the membrane, pore, analyte, and the like.
  • the method further comprises converting the current-potential curve into a conductance-voltage relationship at a given voltage. In some embodiments, the method further comprises correcting the measured current signals in the subset for any non- linear ion current- voltage relationship.
  • the method further comprises converting the current-potential curve into a current-nucleic acid distance curve to provide a current pattern corresponding to a segment of the nucleic acid residing in the constriction zone of the nanopore associated with the single translocation step.
  • the converting step comprises modeling the nucleic acid as a spring with a linear restoring force.
  • the current-nucleic acid distance curve of the subset is indicative of the identity of one or more nucleotide residues in the segment.
  • the method comprises repeating one or more of the described steps for one or more additional subsets associated with one or more additional sequential single translocation steps to provide an aggregation of multiple current patterns representing the current through the nanopore as the nucleic acid translocates continuously through the nanopore.
  • the aggregation multiple current patterns is indicative of the identity of one or more nucleotide residues in multiple overlapping segments of the nucleic acid.
  • the method further comprises comparing one or more of the multiple current patterns to current patterns from reference nucleic acids with known correlations between current patterns and sequence.
  • the method further comprises determining the sequence of a portion of the nucleic acid corresponding to the overlapping segments.
  • the method further comprises detecting one or more discontinuities in the aggregation of multiple current patterns. In some embodiments, the method comprises identifying the one or more discontinuities as a forward skip or backstep associated with an aberrant translocation movement of the nucleic acid. In some embodiments, the method further comprises correcting the discontinuity.
  • the step of translocating the nucleic acid through the nanopore from the first conductive liquid medium to the second conductive liquid medium comprises using a molecular brake to regulate a rate of translocation for the nucleic acid in one or more discrete steps.
  • the molecular brake is a molecular motor, such as a translocase, a polymerase, a helicase, an exonuclease, or a topoisomerase.
  • the polymerase is phi29 DNA polymerase, Klenow fragment, or a variant or homolog thereof.
  • the helicase is a Hel308 helicase, a RecD helicase, a Tral helicase, a Tral subgroup helicase, an XPD helicases or a variant or homolog thereof.
  • the exonuclease is exonuclease I, exonuclease III, lambda exonuclease, or a variant or homolog thereof.
  • the topoisomerase is a gyrase or a variant or homolog thereof.
  • the non-constant electrical potential has a periodic function or a random non-periodic function. In some embodiments, the non-constant electrical potential is superimposed onto a constant potential that is between 10 mV and 1 V. In some embodiments, the non-constant electrical potential is superimposed over a constant electrical potential that is between 10 mV and 300 mV. In some embodiments, the periodic function of the non-constant electrical potential has minimum to maximum difference of less than 250 mV. In some embodiments, the periodic function of the non- constant electrical potential has a period of between 0.1 ms and 1 s. In some embodiments, the periodic function is triangular, sawtooth, square, sinusoidal, a custom function, or linear combinations thereof. In some embodiments, the periodic function is optimized to promote a substantially constant rate of nucleic acid movement within the nanopore during a period of increasing or decreasing potential in the periodic function.
  • the nanopore is a solid-state nanopore, protein nanopore, a hybrid solid state-protein nanopore, a biologically adapted solid-state nanopore, or a DNA origami nanopore.
  • the protein nanopore is alpha-hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP), WZA, lysenin or a homolog or variant thereof.
  • the protein nanopore sequence is modified to contain at least one amino acid substitution, deletion, or addition.
  • the at least one amino acid substitution, deletion, or addition results in a net charge change in the nanopore.
  • the protein nanopore has a constriction zone with a non-negative charge.
  • the disclosure provides a nanopore system.
  • the nanopore system provides a membrane separating a first conductive liquid medium and a second conductive liquid medium;
  • nanopore comprising a constriction zone and a vestibule that together define a tunnel
  • nanopore is disposed in the membrane to provides liquid communication between the first conductive liquid medium and the second conductive liquid medium through the tunnel;
  • constriction zone is more proximate to the first conductive liquid medium and the vestibule is more proximate to the second conductive liquid medium; wherein the system is operative to translocate a nucleic acid from the first conductive liquid medium to the second conductive liquid medium.
  • the membrane is a lipid bilayer. In some embodiments, the membrane comprises a block copolymer. In some embodiments, the nanopore is a solid- state nanopore, protein nanopore, a hybrid solid state-protein nanopore, a biologically adapted solid-state nanopore, a graphene nanopore, or a DNA origami nanopore.
  • the protein nanopore is an alpha-hemolysin, leukocidin, Mycobacterium smegmatis porin A (MspA), outer membrane porin F (OmpF), outer membrane porin G (OmpG), outer membrane phospholipase A, Neisseria autotransporter lipoprotein (NalP), WZA, lysenin or a homolog or variant thereof.
  • the protein nanopore sequence is modified to contain at least one amino acid substitution, deletion, or addition. In some embodiments, the at least one amino acid substitution, deletion, or addition results in a net charge change in the nanopore.
  • the disclosure provides a method for analyzing a nucleic acid in the nanopore system, as described herein.
  • the method comprises:
  • nucleic acid is associate with molecular brake in the first conductive liquid medium that regulates the translocation velocity of the nucleic acid through the nanopore, and wherein the molecular brake has a diameter that exceed a diameter of the nanopore.
  • the molecular brake is disposed within 4 nm of the constriction zone of the nanopore during translocation of the nucleic acid.
  • the molecular brake is an enzyme capable of associating with the nucleic acid, for example, a translocase, a polymerase, a helicase, an exonuclease, or a topoisomerase.
  • FIGURE 1 is a cartoon representation of single stranded DNA (ssDNA) an MspA nanopore embedded in a lipid bilayer membrane, according to an embodiment of the present disclosure.
  • the MspA is illustrated with a single stranded nucleic acid molecule extending between the cis compartment and the trans compartment through the MspA.
  • FIGURE 2 is a cartoon representation of the constriction zone of MspA with a nucleic acid positioned therein.
  • the relative intensity of the shading in the constriction zone represents the increasing influence of any nucleic acid nucleotide at that position on the measured current through the nanopore, and reflects the fact that Brownian motion moves the nucleic acid in and out of the constriction zone.
  • a plurality of nucleotides differentially influence the measured current signal as they pass through the nanopore during translocation of the nucleic acid through the nanopore.
  • FIGURE 3 is a cartoon representation of MspA embedded within a lipid bilayer in an electrolyte solution (not shown).
  • Single stranded DNA (ssDNA) is attached to a bulky NeutrAvidin molecule with a biotin linker.
  • ⁇ trans + the ssDNA threads through MspA from the cis side and remains immobilized until the applied voltage is reversed ⁇ trans -).
  • the nucleotides residing in the narrowest part of MspA, the constriction modulate the ionic current through the pore.
  • FIGURE 4 graphically illustrates voltage-dependent resistance of the DNA-pore system, indicating that the nanopore system is non-ohmic.
  • the voltage dependent resistance of the DNA-pore system is shown for homopolymer adenine ('poly-dA', circles), cytosine ('poly-dC, squares), and thymine ('poly-dT', triangles) for both 3'- leading (solid) and 5'- leading (open) orientations.
  • the resistance of MspA without DNA present is also shown ("Open Pore", x's).
  • FIGURE 5 graphically illustrates the fluctuations of inter-event resistance for nanopore-analyte complexes. Average standard deviations of the DNA-pore resistance within an event is shown above for homopolymer DNA strands. For all strands, the fluctuation of ionic current within an event decreases with higher voltage.
  • FIGURE 6 graphically illustrates the effect of single nucleotide substitutions at various locations in the nucleic acid on the resistance of the nucleic acid.
  • the figure shows a comparison of resistance for DNA with a single cytosine (dC) substitution at position X in an otherwise poly-dA strand (3' leading). The deviation of resistance from that of poly-dA is shown.
  • the top of each plot corresponds to the resistance for a poly- dC strand.
  • the vertical dashed lines indicate the peak of the fitted Gaussian curves.
  • FIGURE 7 graphically illustrates the differential positioning of ssDNA within MspA with varying voltage.
  • the nucleotide positions centrally residing in MspA's constriction zone are shown at each voltage for the dA strand (circles), dT strand (squares), and SNP strand (triangles).
  • the upper panel illustrates that the central nucleotide is taken from the peak of the fitted Gaussian curve as shown in FIGURE 6.
  • the lower panel illustrates the FWHM of the Gaussian curve as shown in FIGURE 6.
  • the error bars indicate the standard errors in the Gaussian fit for each parameter. Voltage dependent stretching of the DNA within MspA is observed by the voltage dependent shifting of the nucleotides in MspA's constriction zone.
  • FIGURE 8 graphically illustrates experimental results for single nucleotide substitutions (SNP) in poly-dT strands that are immobilized in MspA.
  • the panels provide a comparison of resistance for ssDNA with a single adenine (dA) substitution at position X in an otherwise poly-dT strand at different applied voltages.
  • the deviation of the resistance from that of poly-dT (horizontal line at 0) is shown.
  • the top of each plot corresponds to the resistance for a poly-dA strand.
  • the central nucleotide in the constriction zone (vertical dashed line) is taken as the peak of the fitted Gaussian curve and the width of the recognition site is taken as the full width at half max (FWHM).
  • FIGURE 9 graphically illustrates experimental results for single nucleotide polymorphism strands.
  • the panels provide a comparison of the voltage dependent resistance of the DNA-pore system for experiments with a single adenine (dA) or cytosine (dC) substitution at nucleotide position X from the NeutrAvidin anchor in a heteromeric strand.
  • the difference in resistance of for the dA and dC substitutions is shown for each nucleotide position and voltage.
  • the top of each graph corresponds to the difference in resistance expected for poly-dC and poly-dA.
  • the central nucleotide in the constriction (vertical red dashed line) is taken as the peak of the fitted Gaussian curve and the width of the constriction is taken as the full width at half max (FWHM).
  • FIGURE 10 graphically illustrates calculations of force applied to ssDNA within MspA by the application of different voltages.
  • the force applied to DNA in MspA's constriction is calculated at each applied voltage using the freely jointed chain (FJC) model and force relationship (Eqns 2 - 3).
  • FIGURE 11 graphically illustrates the elasticity of ssDNA.
  • the spring constant is determined from the FJC model (Eqn 3) using experimentally derived contour length of the ssDNA, L, as described in more detail below.
  • FIGURE 12 graphically illustrates the width of the MspA recognition site compared to Brownian motion calculations of DNA immobilized in MspA.
  • the recognition sites determined from experiment are the FWHM from the Gaussian curve fitted to experimental results assuming an interphosphate distance of 0.56 nm (FIGURE 6).
  • the Brownian motion values are determined as described in the text. Plots are shown for single dC substitution in poly-dA strand (top panel), single dA substitution in poly-dT strand (middle panel), SNP strand (bottom panel).
  • FIGURE 13 graphically illustrates the force-extension curves for immobilized ssDNA modeled as a Freely Jointed Chain (FJC).
  • Force extension curves for a FJC (Eqn 3) are plotted for each voltage using contour lengths, L, found experimentally.
  • the curve for an applied voltage of 180 mV (dashed) is compared to the curves for each lower voltage (solid).
  • the star indicates the position where the end-to-end distances of the strand, x, are equal and the forces are related by Eqn 2.
  • FIGURES 14A-14F illustrates the current observed when DNA is moved through a nanopore.
  • FIGURE 14A is a cartoon diagram of the constriction zone of MspA with ssDNA (represented with balls and sticks) threaded and influencing the resistance, primarily due to the nucleotides within the sensing zone (shaded area).
  • FIGURE 14B graphically illustrates the expected average current as DNA is moved, adiabatically, continuously or in small steps. This representation is referred to as a "continuous current profile”.
  • FIGURE 14C graphically illustrates the corresponding average current expected to be observed when DNA is moved in single nucleotide steps by a polymerase such as phi29 DNA polymerase.
  • FIGURE 14D is a cartoon diagram illustrating that an increased force on the ssDNA repositions the ssDNA within the nanopore by an amount, ⁇ , referred to as the "registration shift”.
  • FIGURE 14E graphically illustrates the shifting the continuous current profile resulting changes the nucleotides in the ssDNA sensing zone.
  • FIGURE 14F graphically illustrates the corresponding average levels when DNA is moved in single nucleotide steps at the increased force applied in FIGURE 14D.
  • FIGURE 15 graphically illustrates a comparison of current profiles generated from the same nucleic acid polymer, but with separately applied currents of 160 mV and 180 mV.
  • FIGURE 15 (top panel) graphically illustrates the 180 mv data (circles) overlayed with 160 mV data (triangles), scaled for comparison. The inset shows a representative region and demonstrates the offsetting that occurred.
  • FIGURE 15 (bottom panel) graphically illustrates that after correction for the offsetting, the 160 mV data falls very neatly on the 180 mV line.
  • FIGURES 16A-16C graphically illustrate the registration shift, ⁇ , resulting from the application of two different electrical potentials, 160 mV and 180 mV.
  • FIGURE 16A is a graphic representation of an overlay of the step-wise sampling of current from the same nucleic acid analyte with 160 mV and 180 mV.
  • FIGURE 16B illustrates the voltage shift from 160 mV compared to the phase at 160 mV as calculated from data with Eqn 5 (dashed, horizontal line). The fit (solid, curved line) is described by Eqn 7 as adapted for the nanopore system from a modified Freely Jointed Chain (FJC). Error bars are taken from averaging the ⁇ (V), from at least 10 events and at least two experiments.
  • FIGURE 16C is a cartoon diagram of the nanopore indicating the parameters corresponding to the variables used in Eqn 7.
  • FIGURE 17 is a schematic representation of one embodiment of the present disclosure for obtaining sequence information from a nucleic acid analyte in a nanopore system using a non-constant electrical potential. Optional steps are indicated in dashed lines.
  • FIGURES 18A-18C are illustrative examples of raw current signals obtained during the translocation of an ssDNA analyte through an MspA nanopore with the application of a non-constant electrical potential.
  • the series from 18A-18C illustrates the raw current signals with increasing resolution (i.e., over reduced time scales).
  • the arrow indicates the transition to a new level, indicating a translocation step event by the ssDNA.
  • FIGURE 19 is an illustrative depiction of raw current signals during the translocation of an ssDNA through MspA during the application of a non-constant electrical potential.
  • the arrow indicates the transition to a new level, indicating a translocation step event by the ssDNA
  • FIGURE 20 is an illustrative example of the current-potential curves corresponding to multiple enzyme-assisted translocation steps identified in the raw current signals. Each curve is represented on its own current to voltage scale.
  • FIGURE 21 graphically illustrates the corrected current to voltage relationship, indicating that current signals collected across a range of electrical potentials can be converted to remove voltage dependency because the illustrated curves lack slope or other structure dependent on voltage.
  • FIGURES 22A and 22B are illustrative examples of a continuous current profile generated from the current-potential curves illustrated in FIGURE 20. The continuous current profiles are generated by converting the voltage variable to nucleic acid position using a modeled as a Freely Jointed Chain (FJC) model.
  • FIGURE 22A illustrates the continuous current profile as current vs. distance in nucleotides.
  • FIGURE 22B illustrates the continuous current profile as current vs. distance in nm.
  • FIGURE 23 is a cartoon illustration comparing a nanopore system with an MspA nanopore in the forward orientation (left diagram) with a nanopore system with an MspA nanopore in the reverse orientation (right diagram).
  • FIGURE 24 graphically illustrates the contrasting current-to-voltage characteristics of MspA nanopores in forward and reverse orientations, in the absence of analyte.
  • the dashed lines represent the observed characteristics when the poles and applied voltages were reversed for the nanopores in the forward orientation.
  • FIGURES 25A-25B graphically illustrate current observed in a reverse-oriented MspA nanopore without and with analyte, respectively.
  • FIGURE 25A illustrates gating events initially observed when applying an electrical potential to an MspA nanopore in the reverse orientation in the absence of any analyte.
  • FIGURE 25B illustrates the various current levels observed during the translocation of a nucleic acid analyte, indicating that the reverse nanopore is functional for analyzing a translocating nucleic acid.
  • FIGURES 26A-26B graphically illustrate comparisons of current signal resolution provided by MspA nanopores in the forward and reverse orientations.
  • FIGURE 26 A illustrates the auto-correlation (i.e., correlation of a current signal with itself and current signals at adjacent positions). As the lag increases, the correlations of observed current is reduced at a greater rate in a reverse pore than in a forward pore.
  • FIGURE 26B illustrates the nucleotide-specific reponse of the forward (solid line) and reverse (dashed) MspA nanopores. The backwards pore response is narrower and more specific than the forwards pore.
  • FIGURE 26C illustrates the distribution of currents observed in forward (solid) and reverse (dashed) MspA nanopores using the same ssDNA analyte.
  • the present disclosure generally relates to the field of nanopore-based analysis of polymers, such as RNA and DNA polymers.
  • the present disclosure is based in part on a preliminary force spectroscopy investigation on single stranded DNA (ssDNA) within a nanopore.
  • ssDNA single stranded DNA
  • the inventors found that an anchored DNA analyte stretches within the constriction zone of MspA with increasing force, as applied with an increased electric potential in the nanopore system.
  • the stretching of the DNA within the nanopore was characterized at angstrom-level precision.
  • the relative positions of the nucleotides were characterized during the stretch events.
  • Brownian motion was established.
  • the present inventors applied non-constant electrical potentials to cause the DNA to stretch during each stepwise translocation event caused by a molecular brake. Because of the insight from the initial spring modeling analysis, the measured currents were associated specifically with the applied non-constant electrical potential to provide informative current-potential curves for each translocation step. Furthermore, the positions of the nucleotides were then calculated at any point during the DNA stretching and were correlated with the current levels measured throughout each step of translocation. By performing such an analysis for multiple steps in the stepwise translocation, the inventors were able to generate a continuous current profile to reflect the passage of the DNA as if it passed smoothly and continuously through the nanopore.
  • the inventors were able to modify the extant nanopore -based approaches to take advantage of the slowing effect of a molecular brake while avoiding the limitations of blockade measurements in discrete locations, resulting in a much more sensitive analysis of the nucleic acid.
  • the present disclosure provides numerous practical advantages.
  • the current-potential curves associated with a single translocation event e.g., the passage of a single nucleotide residue
  • This makes prediction of the k-mer sequence much more robust and simple because there is much less likelihood that any other possible k-mer sequence will result in a current-potential curve profile with the same characteristics.
  • Simple modifications can be implemented to provide for enhanced accuracy of the derived current-potential curve. For example, a non-constant current can be implemented in a cycle that repeats multiple times during each enzyme-assisted translocation step.
  • nucleic acid refers to any polymer molecule that comprises multiple nucleotide subunits (i.e., a polynucleotide).
  • Nucleic acids encompassed by the present disclosure can include deoxyribonucleotide polymer (DNA), ribonucleotide polymer (RNA), cDNA or a synthetic nucleic acid known in the art, such as peptide nucleic acid (PNA), glycerol nucleic acid (GNA), threose nucleic acid (TNA), locked nucleic acid (LNA) or other synthetic polymers with nucleotide side chains, or any combination thereof.
  • the nucleic acids can be in either single- or double-stranded form, or comprise both single and double stranded portions.
  • cDNA, RNA, GNA, TNA or LNA are single stranded.
  • DNA can be either double stranded (dsDNA) or single stranded (ssDNA).
  • nucleotide subunits of the nucleic acids can be naturally occurring or artificial or modified.
  • a nucleotide typically contains a nucleobase, a sugar and at least one phosphate group.
  • the nucleobase is typically heterocyclic. Suitable nucleobases include purines and pyrimidines and more specifically adenine (A), guanine (G), thymine (T) (or typically in RNA, uracil (U) instead of thymine (T)), and cytosine (C).
  • the sugar is typically a pentose sugar.
  • Suitable sugars include, but are not limited to, ribose and deoxyribose.
  • the nucleotide is typically a ribonucleotide or deoxyribonucleotide.
  • the nucleotide typically contains a monophosphate, diphosphate or triphosphate. These are generally referred to herein as nucleotides or nucleotide residues to indicate the subunit. Without specific identification, the term nucleotides, nucleotide residues, and the like, is not intended to imply any specific structure or identity.
  • nucleotides addressed herein can also be synthetic, modified (such as by epigenetic modifications), or damaged.
  • the nucleotide can be labeled or modified to act as a marker with a distinct signal.
  • modifications can be applied to the nucleic acid before analysis that selectively affects the structure of a limited nucleotide-type to enhance the differentiation of the resulting signal.
  • PCT/US2014/53754 incorporated herein by reference in its entirety.
  • the disclosure also encompasses uses to identify the absence of a base, for example, an abasic unit or spacer in the polynucleotide.
  • polymer analytes such as nucleic acids can be assessed using a nanopore system.
  • nanopore specifically refers to a pore typically having a size of the order of nanometres that allows the passage of analyte polymers, such nucleic acids, therethrough.
  • nanopores encompassed by the present disclosure have an opening with a diameter at its most narrow point of about 0.3 nm to about 2 nm.
  • Nanopores useful in the present disclosure include any pore capable of permitting the linear translocation of the analyte polymer from one side to the other at a velocity amenable to monitoring techniques, such as techniques to detect current fluctuations.
  • Nanopores can be biological pores or solid state pores.
  • the nanopore comprises a protein, such as alpha- hemolysin, anthrax toxin and leukocidins, and outer membrane proteins/porins of bacteria such as Mycobacterium smegmatis porins (Msp), including MspA, outer membrane porins such as OmpF, OmpG, OmpATb, and the like, outer membrane phospholipase A and Neisseria autotransporter lipoprotein (NalP), and lysenin, as described in U.S. Pub. No. US2012/0055792, International PCT Pub. Nos.
  • Msp Mycobacterium smegmatis porins
  • outer membrane porins such as OmpF, OmpG, OmpATb, and the like
  • NalP Neisseria autotransporter lipoprotein
  • lysenin as described in U.S. Pub. No. US2012/0055792, International PCT Pub. Nos.
  • Nanopores can also include alpha-helix bundle pores comprise a barrel or channel that is formed from a- helices. Suitable a-helix bundle pores include, but are not limited to, inner membrane proteins and an outer membrane proteins, such as WZA and ClyA toxin. The nanopore can also be a homologs or derivative of any nanopore illustrated above.
  • a “homolog,” as used herein, is a gene or protein from another species that has a similar structure and evolutionary origin.
  • homologs of wild-type MspA such as MppA, PorMl, PorM2, and Mmcs4296
  • Protein nanopores have the advantage that, as biomolecules, they self- assemble and are essentially identical to one another.
  • Such derivatives can result from substituting amino acid residues for amino acids with different charges, from the creation of a fusion protein (e.g., an enzyme+alpha-hemolysin).
  • the protein nanopores can be wild-type or can be modified to contain at least one amino acid substitution, deletion, or addition.
  • the at least one amino acid substitution, deletion, or addition results in a different net charge of the nanopore.
  • the different in net charge increases the difference of net charge as compared to the first charged moiety of the polymer analyte. For example, if the first charged moiety has a net negative charge, the at least one amino acid substitution, deletion, or addition results in a nanopore that is less negatively charged. In some cases, the resulting net charge is negative (but less so), is neutral (where it was previously negative), is positive (where it was previously negative or neutral), or is more positive (where it was previously positive but less so).
  • the nanopores can include or comprise DNA-based structures, such as generated by DNA origami techniques.
  • DNA origami-based nanopores for analyte detection, see PCT Pub. No. WO2013/083983, incorporated herein by reference.
  • the nanopore is an MspA or homolog or derivative thereof.
  • MspA is formed from multiple monomers.
  • the pore may be homomonomeric or heteromonomeric, where one or more of the monomers contains a modification or difference from the others in the assembled nanopore. Descriptions of modifications to MspA nanopores have been described, see U.S. Pub. No. 2012/0055792, incorporated herein by reference in its entirety.
  • MspA nanopores can be modified with amino acid substitutions to result in a MspA mutant with a mutation at position 93, a mutation at position 90, position 91, or both positions 90 and 91, and optionally one or more mutations at any of the following amino acid positions: 88, 105, 108, 118, 134, or 139, with reference to the wild type amino acid sequence.
  • the MspA contains the mutations D90N/D91N/D93N, with reference to the wild type sequence positions (referred to therein as "Ml MspA" or "Ml-NNN").
  • the MspA contains the mutations
  • M2MspA D90N/D91N/D93N/D118R/D134R E139K, with reference to the wild type sequence positions (referred to therein as "M2MspA"). See U.S. Pub. No. 2012/0055792.
  • Such mutations can result in a MspA nanopore that comprises a vestibule having a length from about 2 to about 9 nm and a diameter from about 2 to about 6 nm, and a constriction zone having a length from about 0.3 to about 3 nm and a diameter from about 0.3 to about 3 nm, wherein the vestibule and constriction zone together define a tunnel.
  • the amino acid substitutions described in these examples provide a greater net positive charge in the vestibule of the nanopore, further enhancing the energetic favorability of interacting with a negatively charged polymer analyte end.
  • FIGURE 1 illustrates an exemplary embodiment where MspA (30) is disposed in a lipid bilayer membrane (20).
  • the MspA nanopore (30) comprises an outer entrance rim region (40), and a vestibule (50) and a constriction zone (60).
  • the vestibule (50) and a constriction zone (60) together form a tunnel.
  • a "vestibule” refers to the cone-shaped portion of the interior of the nanopore whose diameter generally decreases from one end to the other along a central axis, where the narrowest portion of the vestibule is connected to the constriction zone.
  • the vestibule may generally be visualized as "goblet-shaped.” Because the vestibule is goblet-shaped, the diameter changes along the path of a central axis, where the diameter is larger at one end than the opposite end. The diameter may range from about 2 nm to about 6 nm.
  • the diameter is about, at least about, or at most about 2, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, or 6.0 nm, or any range derivable therein.
  • the length of the central axis may range from about 2 nm to about 6 nm.
  • the length is about, at least about, or at most about 2, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, 4.8, 4.9, 5.0, 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, 5.8, 5.9, or 6.0 nm, or any range derivable therein.
  • diameter When referring to "diameter” herein, one can determine a diameter by measuring center-to-center distances or atomic surface-to-surface distances.
  • constriction zone generally refers to the narrowest portion of the tunnel of the nanopore, in terms of diameter, that is connected to the vestibule.
  • the length of the constriction zone can range, for example, from about 0.3 nm to about 20 nm.
  • the length is about, at most about, or at least about 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, or 3 nm, or any range derivable therein.
  • the diameter of the constriction zone can range from about 0.3 nm to about 2 nm.
  • the diameter is about, at most about, or at least about 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, or 3 nm, or any range derivable therein.
  • the range of dimension can extend up to about 20 nm.
  • the constriction zone of a solid state nanopore is about, at most about, or at least about 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 1,2 13, 14, 15, 16, 17, 18, 19, or 20 nm, or any range derivable therein. Larger dimension in such nanopores can be preferable depending on the analyte.
  • the constriction zone is generally the part of the nanopore structure where the presence of a polymer analyte, such as a nucleic acid, can influence the ionic current from one side of the pore to the other side of the nanopore.
  • FIGURE 2 provides an illustrative diagram of a constriction zone (60) that is sensitive to a subsequence of several nucleotides of a polymer (represented by a ball and stick chain). In this example, a specific position within the constriction zone (60) has the highest sensitivity for determining the current through the nanopore.
  • the dimensions of the nanopore's constriction zone can influence the resolution of the current signal as it relates to the structure (and sequence identity) of the analyte polymer residing therein.
  • the term "constriction zone" is used in a functional context based on the obtained resolution of the nanopore and, thus, the term is not necessarily limited by any specific parameter of physical dimension.
  • a nanopore's functional constriction zone can be optimized by modifying aspects of the nanopore system but without providing for any physical modification to the nanopore itself.
  • the nanopore can be a solid state nanopore.
  • a solid-state layer is not of biological origin.
  • a solid state layer is not derived from or isolated from a biological environment such as an organism or cell, or a synthetically manufactured version of a biologically available structure.
  • Solid state nanopores can be produced as described in U.S. Patent Nos. 7,258,838 and 7,504,058, incorporated herein by reference in their entireties.
  • solid state layers can be formed from both organic and inorganic materials including, but not limited to, microelectronic materials, insulating materials such as Si3N4, A1203, and SiO, organic and inorganic polymers such as polyamide, plastics such as Teflon® or elastomers such as two-component addition-cure silicone rubber, and glasses.
  • the solid state layer may be formed from graphene. Suitable graphene layers are disclosed in WO 20091035647 and WO-20111046706.
  • Solid state nanopores have the advantage that they are more robust and stable. Furthermore, solid state nanopores can in some cases be multiplexed and batch fabricated in an efficient and cost-effective manner. Finally, they might be combined with microelectronic fabrication technology.
  • the nanopore comprises a hybrid protein/solid state nanopore in which a nanopore protein is incorporated into a solid state nanopore.
  • the nanopore is a biologically adapted solid- state pore.
  • the nanopore is disposed within a membrane, thin film, layer, or bilayer.
  • biological e.g., proteinaceous
  • an amphiphilic layer such as a biological membrane, for example a lipid bilayer.
  • An amphiphilic layer is a layer formed from amphiphilic molecules, such as phospholipids, which have both hydrophilic and lipophilic properties.
  • the amphiphilic layer may be a monolayer or a bilayer.
  • the amphiphilic layer may be a co-block polymer.
  • a biological pore may be inserted into a solid state layer.
  • the membrane, thin film, layer, or bilayer typically separate a first conductive liquid medium and a second conductive liquid medium to provide a nonconductive barrier between the first conductive liquid medium and the second conductive liquid medium.
  • the nanopore thus, provides liquid communication between the first and second conductive liquid media.
  • the pore provides the only liquid communication between the first and second conductive liquid media.
  • the liquid media typically comprises electrolytes or ions that can flow from the first conductive liquid medium to the second conductive liquid medium through the interior of the nanopore. Liquids employable in methods described herein are well-known in the art. Descriptions and examples of such media, including conductive liquid media, are provided in U.S. Patent No. 7,189,503, for example, which is incorporated herein by reference in its entirety.
  • the first and second liquid media may be the same or different, and either one or both may comprise one or more of a salt, a detergent, or a buffer. Indeed, any liquid media described herein may comprise one or more of a salt, a detergent, or a buffer. Additionally, any liquid medium described herein may comprise a viscosity-altering substance or a velocity-altering substance.
  • the polymer analyte (e.g., nucleic acid) serving as the target or focus of an analysis is capable of interacting with the nanopore and translocating, preferably in a linear fashion, through the nanopore to the other side.
  • the terms “interact” or "interacting,” indicate that the analyte moves into at least an interior portion of the nanopore and, optionally, moves through the nanopore.
  • the terms “through the nanopore” or “translocate” are used to convey that at least some portion (i.e., at least one subunit) of the polymer analyte enters one side of the nanopore and moves to and out of the other side of the nanopore.
  • the first and second conductive liquid media located on either side of the nanopore are referred to as being on the cis and trans regions, where the polymer analyte to be measured generally translocates from the cis region to the trans region through the nanopore.
  • FIGURE 1 An ssDNA (10) is illustrated as residing along the entire internal tunnel of the MspA nanopore (30).
  • the area above the lipid bilayer (20) is the cis compartment that contains the negative pole and the area below the lipid bilayer (20) is the trans compartment that contains the positive pole.
  • Downward movement of the ssDNA (10) through the nanopore would be a translocation of the ssDNA from the cis to the trans regions.
  • the polymer analyte to be analyzed can translocate from the trans region to the cis region through the nanopore.
  • the entire length of the polymer does not pass through the pore, but portions or segments of the polymer pass through the nanopore for analysis.
  • the directionality and rate of translocation can be regulated using various mechanisms such as applied current, additional molecular brakes or motors, or the incorporation of a nanopore in the reverse orientation, as described in more detail below.
  • Nanopore systems also incorporate structural elements to measure and/or apply an electrical potential across the nanopore-bearing membrane or film.
  • the system can include a pair of drive electrodes that drive current through the nanopores.
  • the negative pole is disposed in the cis region and the positive pole is disposed in the trans region.
  • the system can include one or more measurement electrodes that measure the current through the nanopore.
  • These can include, for example, a patch-clamp amplifier or a data acquisition device.
  • nanopore systems can include an Axopatch-IB patch-clamp amplifier (Axon Instruments, Union City, CA) to apply voltage across the bilayer and measure the ionic current flowing through the nanopore.
  • the applied electrical field includes a direct or constant current that is between about 10 mV and about 1 V.
  • the applied current includes a direct or constant current that is between about lO mV and 300 mV, such as about 10 mV, 20 mV, 30 mV, 40 mV, 50 mV, 60 mV, 70 mV, 80 mV, 90 mV, 100 mV, l lO mV, 120 mV, 130 mV, 140 mV, 150 mV, 160 mV, 170 mV, 180 mV, 190 mV, 200 mV, 210 mV, 220 mV, 230 mV, 240 mV, 250 mV, 260 mV, 270 mV, 280 mV, 290 mV, 300 mV, or any voltage therein.
  • the applied electrical field is between about 40 mV and about 200 mV. In some embodiments, the applied electrical field includes a direct or constant current that is between about 100 mV and about 200 mV. In some embodiments, the applied electrical direct or constant current field is about 180 mV. In other embodiments where solid state nanopores are used, the applied direct or constant current electrical field can be in a similar range as described, up to as high as 1 V. As will be understood, the voltage range that can be used can depend on the type of nanopore system being used and the desired effect.
  • the present disclosure addresses the application of a non-constant current to the nanopore system as the nucleic acid is translocating.
  • illustrative parameters and approaches are provided in more detail below.
  • the electrical potential applied can be sufficient to translocate a polymer analyte (e.g., nucleic acid) through the nanopore.
  • a polymer analyte e.g., nucleic acid
  • additional components are incorporated that facilitate or regulate the translocation of the polymer through the nanopore.
  • the component is a molecular brake, which is a moiety that regulates the rate of translocation of the polymer analyte through the nanopore.
  • Molecular brakes can be any protein, enzyme, or molecule that can associate with the polymer analyte (e.g., nucleic acid analyte).
  • the molecular brake has a physical size or shape that prevents its own translocation through the nanopore or is or comprises a tether to an immobile object.
  • FIGURE 3 illustrates a molecular brake (30) that is linked to a ssDNA molecule (90) by a biotin linker (80).
  • a ssDNA molecule 90
  • a biotin linker 80
  • the molecular brake facilitates movement of a nucleic acid polymer through the nanopore.
  • the molecular brake can be active, i.e., using energy such as ATP to move the nucleic acid.
  • Such molecular brakes can encompass moieties that can move the DNA against the force direction applied by the voltage cross the nanopore.
  • the molecular brake can be passive, i.e., not using energy to move the nucleic acid.
  • Molecular brakes can be any known molecular motor that associates with nucleic acids. Typically, such molecular motors are enzymes that are known to associate and manipulate nucleic acids.
  • molecular motors will allow or regulate the translocation of the nucleic acid in a stepwise fashion where the nucleic acid progresses in discrete movements of a relatively consistent length, akin to a ratchet or queuing motion.
  • some molecular motors facilitate translocation of the nucleic acid in single nucleotides steps.
  • other molecular motors are useful for translocating the nucleic acid in steps that are less than a single nucleotide length.
  • Yet other molecular motors are useful for translocating the nucleic acid in steps that are more than a single nucleotide in length.
  • the translocation velocity is less than the translocation velocity that would occur without the molecular brake.
  • the molecular brakes are discussed above with general reference to regulating, and often slowing, the translocation rate, persons familiar with the art will appreciated, however, that some molecular brakes such as molecular motors can be used to speed up or maintain constant translocation rates. Accordingly, the term molecular brake as used herein can encompass moieties that can move the polymer analyte with or against the force applied by an electrical current or flow across the pore.
  • the molecular brake is an enzyme or derived from an enzyme. In some embodiments, the molecular brake is modified to remove a particular function from the enzyme, but preserves the ability of the brake to associate with the polymer analyte (e.g., nucleic acid) and facilitate its translocation.
  • the enzyme is or is derived from a member of any of the Enzyme Classification (EC) groups 3.1.11, 3.1.13, 3.1.14, 3.1.15, 3.1.16, 3.1.21, 3.1.22, 3.1.25, 3.1.26, 3.1.27, 3.1.30 and 3.1.31. The enzyme maybe any of those disclosed in International publication as WO 2010/1086603, incorporated herein by reference in its entirety.
  • the enzyme is a translocase, a polymerase, a helicase, an exonuclease, or topoisomerase, and the like.
  • Exemplary helicases useful for this application are generally described in WO 2010/1086603, incorporated herein by reference in its entirety.
  • Other examples are exonucleases, which can include exonuclease I, exonuclease III, lambda exonuclease, or a variant or homolog thereof.
  • homologs, derivatives, and other variant proteins, as described herein can preferably be at least 50% homologous to the reference protein based on amino acid sequence identity.
  • the variant polypeptide may be at least 55%>, at least 60%>, at least 65%>, at least 70%>, at least 75%>, at least 80%, at least 85%, at least 90% and more preferably at least 95%, 97% or 99% homologous based on amino acid identity to the reference protein.
  • Homology can be determined by any method accepted in the art. It is noted that homologs or variants can possess sequence and structural modifications so long as they retain the proper functionality for translocation. While exonucleases often contain enzymatic functions for excising portions of the nucleic acids, such enzymes can be modified to ablate such nuclease function while preserving the ability to bind and translocate the nucleic acid polymer.
  • Exemplary helicases useful for this application are generally described in WO 2014/013260 and WO 2013/057495, each reference incorporated herein by reference in its entirety, and can include an Hel308 helicase, a RecD helicase, a Tral helicase, a Tral subgroup helicase, an XPD helicases, or a variant or homolog thereof.
  • Exemplary polymerases useful for this application include DNA polymerases such as phi29 DNA polymerase (sometimes referred to as phi29 DNAP), Klenow fragment, or a variant or homolog thereof.
  • DNA polymerase such as phi29 can be used to facilitate movement of the DNA polymer through the nanopore. See, e.g., Cherf, G.M., et al, "Automated forward and reverse ratcheting of DNA in a nanopore at 5-A precision," Nat. Biotechnol.
  • Exemplary topoisomerases can include a gyrase, or a variant or homolog thereof.
  • the method according to this aspect comprises translocating the nucleic acid through a nanopore from the first conductive liquid medium to the second conductive liquid medium, applying a non-constant electrical potential between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid translocates through the nanopore, and measuring a plurality of current signals between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid translocates through the nanopore. Additionally, the method comprises identifying a subset of the plurality of measured current signals associated with a single translocation step of the nucleic acid, and deriving a current-potential curve from the subset of current signals to provide a current pattern. In some embodiments, the method also comprises determining a characteristic of the nucleic acid based on the current pattern.
  • Non-constant electrical potential is applied across the nanopore during the translocation of the nucleic acid. As described above, this is because the inventors have observed the stretch of DNA in the nanopore during the increasing force applied by increasing voltage. The inventors were able to model the stretching phenomenon and characterize the movement of reference nucleic acids within the nanopore constriction zone at different forces (i.e., voltages). Thus, the inventors determined that a shift in the DNA could be imposed, resulting in a corresponding shift in observed current through the pore. With the application of the non-constant electrical potential during translocation the DNA is stretched, and in some embodiments contracted again, once or multiple times, to provide data that ultimately permits simulation of the continuous passage of the nucleic acid through the nanopore.
  • the non-constant electrical potential can have a periodic function or can be random (non-periodic). However, whatever the pattern, the user should know the non- constant potential and be able to correlate it to the measured current signals at any given time.
  • the non-constant electrical potential can be applied across the nanopore by superimposing a non-constant (varying) electrical potential over a constant, direct potential. The general parameters of the constant, direct potential are described above.
  • the non-constant electrical potential is superimposed onto a constant potential that is between 10 mV and 1 V.
  • the non-constant electrical potential is imposed over a constant electrical potential that is between 10 mV and 300 mV.
  • the electrical potential has a periodic function.
  • the periodic function can be asymmetric, symmetric, regular or irregular.
  • the potential can be applied continuously for a period of time, i.e. for a partial period of the period cycle, with a transition between those different potentials, for example a square wave or stepped wave.
  • the transitions between the voltage levels can be sharp or can be ramped over a period of time.
  • the voltage level can vary continuously, for example a triangular, sawtooth, or sinusoidal wave.
  • the periodic function can be customized to achieve a substantially linear rate DNA movement during a period of increasing or decreasing potential in the periodic function.
  • a triangular periodic function might be modified to enhance the time spent at the lower voltages by imposing a low rate of voltage increase at the beginning of the cycle, but followed by an increasing slope until the maximum voltage.
  • the descending portion of the cycle can mirror the increase, such that the time spent at the higher voltages is minimized and the time spent at lower voltages is maximized.
  • the period or cycle of the periodic function is typically shorter than the time required for each translocation step of the nucleic acid. Often, it is preferred to have multiple (and even numerous) periodic function periods occur during each single translocation step as it permits the acquisition of multiple data points at each potential level applied. In some embodiments, the periodic function is between about 0.1 ms and about 1 s (inclusive).
  • the period function is between about 1.0 ms and about 0.5 s, for example between about 1.0 ms and about 0.1 s, between about 1.0 ms and about 0.01 s, between about 5.0 ms and about 0.01 s, between about 10 ms and about 0.01 ms, between about 5.0 ms and about 0.001 s, between about 10 ms and about 0.001 s, and the like.
  • the difference between the minimum and maximum potential in the periodic function is less than 250 mV.
  • the period function does not fluctuate by more than 250 mV, 240 mV, 230 mV, 220 mV, 210 mV, 200 mV, 190 mV, 180 mV, 170 mV, 160 mV, 150 mV, 140 mV, 130 mV, 120 mV, 110 mV, 100 mV, or less.
  • the imposition of the non-constant potential does not reverse the polarity of the nanopore system.
  • Raw current can be continuously or periodically monitored during the application of the non-constant potential, as described above, to produce the plurality of current signals.
  • multiple current signals are obtained during the translocation of each nucleotide.
  • FIGURES 18A-18C illustrate raw current signals obtained during the translocation of a ssDNA through MspA with increasing resolution (i.e., with decreasing time scales). As illustrated, hundreds of current signals can be recorded per second.
  • a subset of current signals associated with a single translocation step is identified.
  • the translocation step can merely be the passage of nucleic acid by one nucleotide subunit.
  • the translocation step can be driven or facilitated by a molecular brake, many of which drive the translocation in single, discrete steps.
  • the subset of current signals can be identified according to any known technique. For example, as described in more detail below, algorithms can be applied to the data to ascertain pattern shifts in the current signals indicating the passage of a nucleotide length, and thus a new k-mer subsequence in the nanopore constriction zone. Such algorithms can be referred to as level finders, with the term level referring to the current signals (often taking the form of a "block” or "level) corresponding to a k-mer with a specific sequence within the constriction zone.
  • level finders with the term level referring to the current signals (often taking the form of a "block” or "level) corresponding to a k-mer with a specific sequence within the constriction zone.
  • the arrows in FIGURES 18C and 19 indicate the transition between levels.
  • a current-potential curve is derived from the subset of current signals.
  • the measured current is associated with the particular electrical potential, usually indicated as a specific voltage, which had been applied to the nanopore system as the current was observed. Because the method employed a non-constant electrical potential, current signals will be associated with at least two distinct potentials to provide the current-potential curve.
  • FIGURE 20 provides and illustrative example of a series of 16 distinct current-potential curves, each corresponding to sequential translocation steps. Each of the illustrated curves contains hundreds of current to voltage (I-V) plots over a range of 100 to 200 mV.
  • each current-potential curve contains a vast amount of information regarding the corresponding sequence of the k-mer residing in the constriction zone of the nanopore at the time the corresponding subset of raw current signals was recorded.
  • the various current-potential curves illustrated contain different lengths, slopes, curvatures, minimum and maximum currents, and the like, all of which can be used to uniquely reflect the structure (e.g., sequence) of the k- mer residing in the constriction zone.
  • the current-potential curve is the current pattern and, thus, the characteristics of the nucleic acids can be identified based on the current-potential curve.
  • curve notwithstanding, it will be appreciated that there is no implied requirement that the relationship of the data creating the curve be displayed, such as in FIGURE 20, for the relationship (i.e., curve) to be used according to the disclosed methods of determining a characteristic of the nucleic acid.
  • corrections, conversions, or modifications can be applied to the current data, including the current-potential curve, to provide the current pattern.
  • Such corrections, conversions, or modifications can be advantageous in various circumstances to correct the signal for various perceived "non-linearities" or other abberations in the system that can otherwise obfuscate the relationship between the structure of the k-mer in the constriction zone and the observed current.
  • the method also comprises a step to correct for measured current not associated with the flow of ions through the nanopore, and thus reduce the influence of this current on the measured current signal.
  • the goal is to obtain observations of the ion current through the pore at any given time without influence or obfuscation by other types of measured currents.
  • the measured current can be affected by the capacitance of various components of the nanopore system.
  • components that can exhibit capacitance are the bilayer membrane, the electronics, or the nanopore setup.
  • the method can include a step of correcting for any capacitance of the system to reduce the influence on the measured current signal.
  • This correction can be implemented by hardware, by providing compensatory electrical potential (e.g., injecting currents as appropriate) to substantially offset any current resulting from charging of capacitances of the nanopore system.
  • the measured current signal itself can be corrected to compensate for any capacitive currents within the nanopore system. This can be accomplished according to any known approach (see below description), and usually involves adjustment of the overall measured data.
  • the method further comprises converting the current-potential curve into a conductance-voltage relationship at a given voltage.
  • This entails removing the voltage dependency of the data, which heretofore reflects the different observed currents at multiple voltages (as applied as a non-constant potential).
  • This conversion can be performed according to any known methods, such as described in more detail below.
  • the current for each current data point can be adjusted to an expected current at single, constant reference voltage of choice. This current transformation emulates the current that would be found if the ssDNA nucleotides were positioned at the given location, while at a constant potential was applied.
  • FIGURES 22A and 22B illustrate current to another parameter.
  • conductance is current divided by voltage. As all of the conductance valued plotted are multiplied at a constant voltage (typically 180 mV), the conductance value is converted to current for purposes of these illustrations.
  • a constant voltage typically 180 mV
  • the MspA nanopore system was non-ohmic, i.e., had a non-linear resistance to voltage relationship. See, e.g., FIGURE 4.
  • the conversion can include correcting for the nonlinearity of the current to voltage relationship. An exemplary correction is described in more detail below, where the non-linear relationships were fit to a quadratic function.
  • the method further comprises converting the current-potential curve into a current-nucleic acid distance curve to provide a current pattern corresponding to a segment of the nucleic acid residing in the constriction zone of the nanopore associated with the single translocation step.
  • This conversion is the result of modeling work described below wherein the elasticity of ssDNA within the nanopore constriction zone was modeled as a spring, thus enabling the characterization of the specific positions of the reference nucleotides during the stretch as increasing force was applied.
  • the fluctuations in applied potential are predictive of the spatial relationship of the nucleotides in the k-mer as to the nanopore constriction zone.
  • the current-potential curves can be converted to show the current-spatial relationships of the k-mer. This effectively describes the current-nucleotide distance (within the nanopore) relationship in the subset of current signals.
  • the conversion of the current-potential curve into a current-nucleic acid distance curve is accomplished by application of a spring-based model.
  • the model is a model of spring with a linear restoring force.
  • the model is a non-linear restoring force as in a freely jointed chain (FJC) model or modified freely jointed chain (FJC) model, as described in more detail below.
  • FJC freely jointed chain
  • FJC freely jointed chain
  • the conversion and correction steps described can be applied optionally and independently to the observed current signals and/or current-potential curves.
  • the inventors have discovered that the data derived from applying a non-constant electric potential during translocation, after a specific conversion process unexpectedly revealed a great quantity of high-resolution data regarding the passage of each nucleotide through the nanopore.
  • the current-potential curves, or any conversions thereof, such as the current-nucleic acid distance curves provides a high order of detailed information that corresponds to the specific k-mer structure (e.g., sequence) passing through the nanopore constriction zone at any given time, even when the translocation is a ratcheted, stepwise process facilitated by a molecular brake.
  • the data obtained for the subset can be useful for predicting the sequence of the corresponding k-mer in the nucleic acid.
  • the method is repeated as described above, including any optional conversion step, for one or more additional subsets of data to provide a plurality of current patterns.
  • the subsets correspond to sequential translocation steps, e.g., the passage of a contiguous sequence of nucleotide subunits through the nanopore.
  • information i.e., current patterns as described above
  • these current patterns provide even further analytic advantages.
  • the prediction of a series of k-mer sequences even if there is redundancy in curves reflecting various k-mers, can be useful to predict with high probability the sequences of the k-mers.
  • HMM Hidden-Markov Models
  • WO 2013/041878 also incorporated herein by reference in its entirety.
  • all potential k- mer nucleic acid sequences for a degenerate sequence are stored.
  • a first output signal is measured to provide a first current pattern, as described above.
  • a second, subsequent output signal is assessed to provide one or more potential k-mer nucleic acid sequences for the second current pattern.
  • All potential k-mer nucleic acid sequences for the first current pattern that are incompatible with the potential k-mer nucleic acid sequences for the second current pattern are discarded. This process can be repeated for more k-mer current patterns.
  • the first measurement yielded many possible k-mer nucleic acid sequences it is likely that after several measurements there will only be one or a few possible sequences that are consistent with all the measurements.
  • the method can also comprise the step of comparing one or more to of the multiple current patterns to current patterns from reference nucleic acids with known correlations between current patterns and sequence, for example, in the form of a look-up table.
  • Such tables can be generated according to ordinary skill in the art.
  • the aggregation of current patterns for sequential translation steps can provide even further advantages, such as the ability to detect discontinuities in the translocation process, and thus deficiencies in the data.
  • the aggregation of current patterns along a distance axis provides a continuous current profile that simulates the dynamic fluctuation of current that would be caused by a nucleic acid polymer during a continuous (not ratcheted, stepwise) translocation through the nanopore.
  • the generated continuous current profile can reveal discontinuities, or aberrations from the continuous pattern.
  • the discontinuity reflects a forward skip in translocation. This could occur, for instance, when a molecular brake that normally permits translocation in single nucleotide steps permits two or more nucleotides to translocate without an intervening pause. Additionally, the discontinuity reflects a backstep during translocation.
  • the molecular brake pulls the nucleic acid backward (e.g., from trans to cis) for a length of the nucleic acid, and then resumes normal forward translocation, effectively allowing the same subsequence to translocate multiple times.
  • Such discontinuities can be readily observed in the generated continuous current profile and disregarded or otherwise accounted for. For skips, often the missing data can be reasonably inferred by imposing a reasonable connection between disconnected portions of the profile. Thus, in some embodiments, the discontinuities are corrected.
  • FIGURE 17 An illustrative, non-limiting embodiment of the present method is represented schematically in FIGURE 17.
  • DNA is tranlocated through a nanopore while applying nonconstant potential and current signals are acquired (110).
  • Exemplary illustrations of the raw signal data are provided in FIGURES 18A-19.
  • the capacitance of the system is corrected by injecting compensatory potential (150) and/or by data correction of the acquired current signals (160).
  • Subsets of data corresponding to individual enzyme-assisted translocation steps are identified (120) by, for example, the use of a level finder algorithm. Such level transitions between the subsets are illustrated in FIGURES 18C and 19.
  • the current-potential (voltage) curves are derived for one or more subset (130), as illustrated in FIGURE 20.
  • the obtained current-potential (voltage) curves can be used to estimate the sequence of one or more nucleotide subunits of the analyte nucleic acid (140).
  • the current-potential (voltage) curves can further be subjected to adjustments, including conversion to remove the voltage dependency (whether linear or non- linear) of the current (170) and/or conversion to a current-nucleic acid position relationship to provide a continuous current profile based on spring modeling (180). See, e.g., FIGURES 22A and 22B. With the generation of a continuous current profile, discontinuities in the translocation process, and resulting data, can be identified and addressed (190).
  • a characteristic of the nucleic acid polymer that is determined in this method can be the identity of one or more of the nucleic acid subunits therein.
  • the characteristic is the presence of one or more modified nucleotide subunits.
  • actual identity does not need to be determined.
  • the method can be used to characterize patterns within the structure (independent of specific sequences) such as a "fingerprint" that can be used to distinguish the nucleic acid relative to another nucleic acid.
  • the sequence identity is determined for one, two, or more (including all) of the nucleotide subunits in the nucleic acid.
  • the measurable signal obtained from nanopore analysis of the nucleic acid is compared against a known signal or a signal obtained from a known nucleic acid.
  • known nucleic acid is used in reference to a nucleic acid for which the status with respect to a particular characteristic, such as nucleotide sequence or fingerprint pattern, is known.
  • the known signal is obtained from the known nucleic acid under the same or similar analytical conditions.
  • the inventors modeled the stretching of DNA in MspA nanopore and identified the influence of Brownian motion on the resolution (or the functional size of the constriction zone). By having nucleotides move in and out to the constrictions zone area, they contribute to the modification of the passing ionic current and, thus, lower the resolution of the pore.
  • the inventors sought to reduce the influence of Brownian motion on the resolution of signals obtained from the nanopore by reducing the distance between the molecular brake and the constriction zone of the nanopore. The inventors hypothesized that a reduced distance would reduce elongational tendencies of the nucleic acid and reduce the Brownian motion.
  • MspA nanopores in the reverse orientation were known to exhibit significant gating when relevant potentials were applied to test for insertion of the pore. Gating refers to spontaneous reductions in current in the absence of an analyte. See, e.g., FIGURE 25A. This gating behavior would be difficult to distinguish from any real signal caused by an analyte.
  • the MspA nanopores tend to insert into the bilayer membranes in the forward orientation when using standard procedures.
  • a system for nanopore-based analysis of a nucleic acid comprising a membrane separating a first conductive liquid medium and a second conductive liquid medium and a nanopore embedded in the membrane that comprises a constriction zone and a vestibule that together define a tunnel.
  • the constriction zone is more proximate to the first conductive liquid medium and the vestibule is more proximate to the second conductive liquid medium.
  • the system is operative to translocate a nucleic acid from the first conductive liquid medium to the second conductive liquid medium.
  • the first conductive liquid medium is typically present in the cis side of the membrane, as illustrated in FIGURE 23. In some embodiments, the cis side of the membrane contains the negative pole of the nanopore system.
  • the membrane is generally described above.
  • the membrane is a lipid bilayer.
  • the membrane comprises a block copolymer.
  • the nanopore can be any nanopore as described herein, which is asymmetrical along the axis of the tunnel and contains a constriction zone.
  • the constriction zone is oriented in the membrane such that the constriction zone is more proximate to the first conductive liquid medium than the second conductive liquid medium.
  • the nucleic acid is associated with a molecular brake.
  • the molecular brake is disposed within the first conductive liquid medium.
  • the molecular brake is a moiety that has a diameter equal to or larger than the internal diameter of the nanopore constriction zone.
  • the molecular brake is or includes a tether linkage to an immobile object.
  • the disclosure provides a method for analyzing a nucleic acid in a nanopore system.
  • the nanopore system can be the system described herein where the nanopore is embedded in the membrane in a "reverse" orientation with the constriction zone more proximate to the first conductive liquid medium.
  • the method includes translocating the nucleic acid through the nanopore from the first conductive liquid medium to the second conductive liquid medium, applying an electrical potential between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid translocates through the nanopore, measuring a plurality of current signals between the first conductive liquid medium and the second conductive liquid medium as the nucleic acid is in the nanopore; and determining a characteristic of the nucleic acid based on the measured current signals.
  • the nucleic acid is associate with molecular brake in the first conductive liquid medium that regulates the translocation velocity of the nucleic acid through the nanopore, and wherein the molecular brake has a diameter that exceed a diameter of the nanopore.
  • the molecular motor does not pass through the nanopore.
  • the molecular motor abuts against the opening of the nanopore (on the cis side) to provide resistance to the translocation rate of the nucleic acid.
  • the distance between the molecular motor and the constriction zone of the nanopore is less than about 4 nm, such as less than about 3 nm, less than about 2nm, and less than about 1 nm.
  • the method steps can generally be performed as described above.
  • the molecular brake and other components of the nanopore system are described in more detail above.
  • the following is a description of a study varied the applied electric potential to alter the force on nucleic acid polymers resulting in differential stretching of the nucleic acid within an MspA nanopore.
  • the study further addresses the analysis of the resulting current signals to characterize and model the stretching of the nucleic acid.
  • MspA Mycobacterium smegmatis porin A
  • mutants thereof has been previously described as part of a nanopore DNA sequencing system with high signal-to- noise resolution of individual nucleotides.
  • the pore was inserted into a lipid bilayer in an electrolyte solution and voltage was applied across the bilayer. DNA nucleotides positioned into the pore's constriction zone were found to modulate the resistance of the DNA-pore system.
  • MspA was used to stretch single-stranded DNA as it was immobilized within the nanopore.
  • the DNA was attached to a large NeutrAvidin molecule and driven into MspA until the NeutrAvidin came to rest on the rim of the pore, prohibiting further translocation. Approximately 15 nucleotides spanned the distance from the NeutrAvidin to the MspA constriction zone. By varying the voltage across the pore, DNA stretching was detected with nucleotide precision. Using a freely jointed chain model, the force applied to the DNA strand was estimated, as well as its charge density and elasticity. The Brownian motion of the strand was also estimated and found to cause multiple nucleotides to control the ionic current through the nanopore. These results provide insight into the behavior of DNA confined within a nanopore and are important for the further refinement of a nanopore DNA sequencing system.
  • Biological nanopores can be used as a single molecule tool to detect individual DNA nucleotides as well as to study protein folding and peptide structure. This simple technique is currently being developed for use as an inexpensive, high-resolution DNA sequencing system.
  • MspA Mycobacterium smegmatis porin A
  • motor enzyme see Manrao, E.A., et al., "Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase," Nature Biotechnology 50:349-353 (2012), incorporated herein by reference in its entirety).
  • MspA is a particularly significant biological nanopore because it provides the highest signal-to-noise resolution of DNA nucleotides to date (Butler, T.Z., et al, "Single-molecule DNA detection with an engineered MspA protein nanopore,” Proceedings of the National Academy of Sciences of the United States of America 705:20647-20652 (2008), incorporated herein by reference in its entirety). Initially negative charges near the constriction of wild type MspA inhibited DNA translocation, but after introduction of mutations in which three negatively charged aspartic acids were replaced with asparagines DNA translocation was observed.
  • MspA This modified porin, referred to hereafter as simply "MspA", demonstrated sensitivity to all four DNA bases (see Manrao, E.A., “Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase,” Nature Biotechnology 50:349-353 (2012) and Derrington, I.M., et al, “Nanopore DNA sequencing with MspA,” Proc. Natl. Acad. Sci.
  • the ionic current through the pore demonstrated distinct levels associated with each single nucleotide movement (see Manrao, E.A., et al., "Reading DNA at single -nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase,” Nature Biotechnology 50:349-353 (2012), incorporated herein by reference in its entirety).
  • the correlation between the ionic current values and the identity of the nucleotides within MspA's constriction was found to be complex. Approximately four nucleotides contribute to the ionic current and it was evident that the precise positioning of the nucleotides within MspA's constriction is an important factor to understanding these observed current levels.
  • a ssDNA polymer is held within a MspA using a bulky molecule as an anchor.
  • Biotinylated ssDNA was bound to a NeutrAvidin molecule and drawn into MspA by an applied voltage of 180 mV.
  • the applied voltage was decreased in 20 mV steps from 180 mV to 80 mV, with each voltage applied for 250 ms. The resulting current was recorded.
  • lipid bilayers were formed across a horizontal ⁇ 20 ⁇ diameter aperture in Teflon from 1 ,2-diphytanoyl-sn-glycero 1-3 -phosphocho line, 1,2- diphytanoyl-sn-glycero-3 -phosphate (Avanti Polar Lipids) or equal mixtures thereof.
  • Compartments on both sides of the bilayer contained experimental buffer of 1.0 M KC1, 10 mM HEPES/KOH buffered at pH 8.0 +/- 0.05.
  • An Axopatch-200B, IB or 1C patch clamp amplifier (Axon Instruments) was used to apply a voltage across the bilayer and measure the ionic current.
  • MspA was added to the grounded cis compartment at a concentration of ⁇ 2.5 ng/ml. Once a single protein was inserted in the bilayer, the cis compartment was flushed with experimental buffer in order to avoid further insertions. All experiments were performed at 23 ⁇ 1°C.
  • the analog ion current signal was low-pass filtered at 20 kHz with a 4-pole Bessel filter and digitized at 100 kHz. Data acquisition was controlled with custom software written in LabWindows/CVI (National Instruments). The pore was held at 180 mV until there was a spontaneous reduction in current to less than 200 pA lasting longer than 100 ms, signifying DNA held threaded through the pore.
  • the voltage was changed in steps of 20 mV from 180 mv down to 80 mV, each step lasting 250 ms. Then -lOOmV was applied for 250 ms to eject the DNA-NeutrAvidin complex out of the pore back into the cis compartment. The voltage then returned to 180 mV to attract another DNA-NeutrAvidin complex
  • the MspA protein was purified from Mycobacterium smegmatis as previously described (Butler, T.Z., et al, "Single-molecule DNA detection with an engineered MspA protein nanopore,” Proceedings of the National Academy of Sciences of the United States of America 705:20647-20652 (2008), incorporated herein by reference in its entirety).
  • DNA with biotin on either the 5' or 3' end was synthesized by Integrated DNA Technologies with standard desalting and no additional purification.
  • NeutrAvidin was obtained from Invitrogen. DNA was mixed in equal molar concentrations with NeutrAvidin to create ssDNA-NeutrAvidin complexes, which were stored at -20°C until immediately before use. For experiments, 5 ⁇ of the ssDNA-NeutrAvidin complex was added to the cis chamber.
  • the homopolymeric adenine (poly-dA), cytosine (poly-dC), and thymine (poly-dT) nucleic acids were examined held within the pore in either orientation (3' or 5' ends threaded through the pore). Based on geometry, approximately 20 nucleotides (nt) adjacent to the biotin anchor were expected to reside in the MspA pore, with the remainder of the strand on the trans side. All strands were 50-65 nt long so that the regions of the nucleic acids within MspA's constriction zone were located in the center of the strand. Homopolymer guanine was not available due to G-tetrad structure formation.
  • the voltage-dependent resistance for each DNA-pore complex is shown in FIGURE 4.
  • Homopolymer cytosine in the 3 '-leading orientation and homopolymer thymine in the 5'- leading orientation produced the highest resistances. Both orientations of homopolymer adenine produced similar resistances, which were found to be the lowest of all strands.
  • Homopolymer cytosine with 5 '-leading had a resistance similar to poly-dA.
  • the resistance of homopolymer cytosine was strongly orientation dependent with the 3'- leading direction having a much higher resistance than that for 5 '-leading direction.
  • the orientation dependence of the DNA-pore resistance has been previously observed and was reasoned to be due to differences in the tilt of the DNA bases while confined in the nanopore.
  • the standard deviation of the DNA-pore resistance for the homopolymer DNA strands is shown in FIGURE 5. At lower voltages, the fluctuation of the resistance within an event was larger than at higher voltages, indicating that the strand is more constrained at higher voltages.
  • Nucleotides located before the 14th position had little to no effect on the resistance, as they were located above MspA's recognition site (i.e., constriction zone). At higher voltages, the nucleotide most affecting the current changed to X ⁇ 14. In addition, the range over which the single dC affects the current is slightly smaller at higher voltages (see FIGURE 7).
  • SNP single nucleotide polymorphism
  • This DNA sequence had a particular nucleotide that was either a dC or a dA (see Table 1 for sequence).
  • the SNP sequence chosen had no more than 2 consecutive base pairing so that effects of secondary structure within MspA emulates genomic DNA.
  • the central nucleotide shifted from X ⁇ 16 at low voltages to X ⁇ 14 at higher voltages (FIGURE 9, discussed in more detail in the Supporting Material).
  • FIGURE 7 compares the nucleotides within MspA's recognition site for the three different DNA strands.
  • the present results indicate that the voltage influences longitudinal positioning of DNA held within MspA.
  • the nucleotide that exhibits the largest effect on the DNA-pore resistance is located at X ⁇ 14 from the biotin anchor.
  • the DNA nucleotides shift upward so that the X ⁇ 16 is centered in the recognition site and the number of nucleotides involved in controlling the ionic current slightly increases (FIGURE 7).
  • the observed shifting of nucleotides in MspA's recognition site relative to the DNA with varying voltages is due to either elongation of the DNA strand or changes in positioning of the biotin anchor with respect to MspA's constriction.
  • Elongation of the ssDNA under force may be caused by base unstacking or a reduction in the curvature of the strand.
  • changes in the positioning of the NeutrAvidin on the pore or deformation of the rim of MspA may cause the entire strand to shift.
  • the fluctuations observed in the DNA-pore resistance within a single event show strong voltage dependence (i.e. force dependence) where the strand is more tightly constrained at higher forces (FIGURE 5). This suggests that the conformation of the DNA strand is changing under increased force.
  • the force on the DNA within Ms A can be estimated as:
  • the number of nucleotides in MspA's recognition site, n are taken as the width of the fitted Gaussian curve as shown in FIGURE 7 (lower panel). Assuming that the number of nucleotides in the MspA recognition site (constriction zone) is proportional to the charge density of DNA in the pore, ⁇ , forces at two voltages, Vi and V 2, can be estimated by:
  • x is the end-to-end distance of the strand
  • L is the contour length
  • b is the Kuhn length
  • kb is the Boltzmann constant
  • T is the temperature.
  • the contour length, L is extracted from experiment as the length of DNA between the NeutrAvidin anchor and the top of the recognition site, assuming an interphosphate distance of 0.56 nm.
  • all three strands had the same nucleotide position, X, centered within MspA's recognition site and therefore it is assumed that the interphosphate distance and Kuhn length are sequence independent.
  • the end-to-end distance of the DNA within the MspA vestibule, x was assumed to be constant whereas the contour length of the strand, L, within this region changed with varying voltage.
  • the applied force and elongation of DNA, x was estimated with the FJC model by comparing the force-extension curves (Eqn 3) at two voltages using the force relationship described above (Eqn 2). See Supporting Material, below, for more details.
  • the estimated forces for each DNA strand are shown in FIGURE 10 and range from 6 to 14 pN for 80 and 180 mV, respectively.
  • the linear charge density of the dA strand was -0.29 eVnt and the charge density of the dT strand and the SNP strand were both -0.22 eVnt.
  • the larger charge density of the dA strand was found from the larger forces observed in FIGURE 10 and indicates that the dA strand is more affected by voltage changes than the other strands.
  • the FWHM of a Gaussian curve fitted to experimental results was used to determine how many nucleotides resided in MspA's recognition site.
  • the width of this Gaussian curve had contributions from both the size of the MspA constriction zone and the Brownian motion of nucleotides. It was assumed that the applied voltage dropped entirely over the MspA constriction zone so that only nucleotides within this region experienced a force. However, it is believed that Brownian motion caused nucleotides around the constriction to move in and out of the electric field making the number of nucleotides affecting the DNA-pore resistance to be larger than expected for a stationary system.
  • the Brownian motion contribution can be compared to the width of the recognition site determined from experiment. See Supporting Material, below, for more details.
  • the results for experiments using the dA, dT and SNP strands are shown in FIGURE 12 (described in more detail in the Supporting Material, below).
  • the contribution from Brownian motion makes up the majority of the width of the recognition site.
  • the width of MspA's constriction is -0.8 +/- 0.2 nm for the dA strand. This agrees favorably with that expected from geometry.
  • the recognition site was smaller than the expected contribution from Brownian motion. While this may be result of imperfections in the experiment it may also suggest that the nucleotides interact with the pore constriction zone, thus constraining their motion.
  • the diameter of the ⁇ -barrel in a-hemolysin is larger than MspA's constriction zone. This increased width is likely responsible for the greater charge shielding in a-hemolysin as water molecules can more easily surround the DNA strand.
  • the effects due to the elasticity of the DNA strand could be minimized by shortening the distance between the anchor point and the constriction. This could be accomplished by holding the DNA in the MspA pore under reverse voltage and with the speed- regulating enzyme (e.g., molecular motor) in the trans side.
  • the system could incorporate the MspA in a reverse orientation, with the constriction zone closer to the cis side and the vestibule closer to the trans side.
  • the change in DNA-pore resistances due to single nucleotide substitutions was observed at various positions along the strand.
  • the DNA-pore resistance and error for a given strand was determined from the mean and standard deviation, respectively, of the resistances frond from multiple experiments.
  • By fitting a Gaussian curve to the results at each applied voltage it was determined which nucleotides comprised the recognition site of MspA from the peak and full width at half max (FWHM) of the fit (FIGURES 6 and 7).
  • the width of the recognition site was comprised of two elements: MspA's constriction zone size and Brownian motion of nucleotides.
  • the constriction zone was the narrowest part of the MspA pore.
  • the strand between the biotin linker and recognition site was modeled as a freely jointed chain (FJC).
  • FJC freely jointed chain
  • the force on the FJC is related to the charge density of DNA, cr, and applied voltage across the pore, V, by:
  • Fi/F 2 (ni/n 2 )*(Vi/V 2 ) [Eqn 2].
  • the Kuhn length, b was estimated as 3.0 nm (Murphy, M.C., et al, "Probing single-stranded DNA conformational flexibility using fluorescence spectroscopy, Biophys. J. #6:2530-2537 (2004), incorporated herein by reference in its entirety) (1M KC1) and the stretch modulus, S, was taken as 800 pN (Smith, S.B., et al, “Overstretching B-DNA: The elastic response of individual double-stranded and single-stranded DNA molecules," Science 277:795-799 (1996), incorporated herein by reference in its entirety).
  • the contour length, L was obtained from experiment as the length of DNA between the biotin and top of the recognition site, assuming an interphosphate distance of 0.56 nm.
  • the extension or end-to-end distance, x was the length of the vestibule between the biotin and top of the recognition site and was taken as unknown and voltage-independent.
  • the applied force and end-to-end distance of the vestibule, x were found with the FJC model by comparing the force-extension curves (Eqn 3) at two voltages using the force relationship found above (Eqn 2). Because 180 mV was the baseline voltage, the extension at each lower voltage was compared to that at 180 mV.
  • the force extension curves for a single dC substitution in poly-dA are shown in FIGURE 13.
  • the average force for an applied voltage of 180 mV found from the FJC comparisons described above was 15.54 +/- 1.81 pN. Forces for each lower voltage were determined using this value and the force relationship from Eqn 2.
  • the extension of DNA, x corresponded to the distance between the biotin linker and top of the recognition site and was found to be 6.76 +/- 0.10 nm. See Table 2. It is noted that for Tables 2-4, the central nucleotide and number of nucleotides in the recognition site are taken from a Gaussian fit to experimental data (FIGURE 6). The errors are the standard errors of the Gaussian fit parameters.
  • the contour length of DNA is measured from the biotin anchor to the top of the recognition site assuming an interphosphate distance of 0.56 nm.
  • the force relationship F(X mV)/F(180 mV) is calculated from Eqn 2 and is used in the FJC model to relate the force extension curves for two voltages.
  • the force at 180 mV and the extension are determined from the FJC model and correspond to the red stars in Figure S2.
  • the force at each lower voltage is determined using the mean value at of the force at 180 mV and the force relationship F(X mV)/F(180 mV).
  • the DNA charge is determined using the curvature of DNA in the pore as described in the text.
  • x and L are the extension and contour length from the FJC model, respectively.
  • SNP Single Nucleotide Polymorphism
  • SNP Single nucleotide polymorphism
  • a Gaussian curve fitted to experimental results was used to determine which nucleotides most affected the DNA-pore resistance.
  • the recognition site of the DNA strand was defined by the FWHM of the Gaussian fit.
  • the recognition site width contained contributions from the width of the MspA constriction zone as well as Brownian motion of nucleotides moving in and out of the constriction. It was estimated that the applied voltage dropped entirely over the constriction so that only nucleotides within this region experienced a force. Brownian motion, however, caused nucleotides around the constriction to move in and out of the electric field making the number of nucleotides affecting the DNA-pore resistance to be larger than expected for a stationary system.
  • ⁇ x 2 > k b T / K [Eqn 4] where kbT is 4.11 pN-nm at room temperature.
  • the width of the Gaussian curve from experimental data was related to the curves from MspA's constriction and Brownian motion by:
  • FWHM experime nt 2 FWHM ' constriction + FWHM brownian ⁇
  • the Width of MspA*S constriction, then, was determined from FWHM constriction FWHM experiment 2 - 8 * ln2 * k b T/ (F/x).
  • FIGURE 12 Comparisons of the Brownian motion calculations and the widths of the recognition sites for experiments using poly-dA, poly-dT and SNP are shown in FIGURE 12.
  • the contributions from Brownian motion account for the majority of the width of the recognition site.
  • the mean width of MspA's constriction was -0.79 +/- 0.23 nm.
  • the recognition site was smaller than the expected contribution from Brownian motion. This suggests that either unstacked DNA strands cannot be modeled as a spring or the nucleotides interacted with the pore constriction constraining their motion.
  • the nanopores such as the protein nanopore Mycobacteria smegmatis porin A (MspA) can be used to examine nucleic acids with sub-angstrom resolution.
  • a controlled voltage can be applied to the system and an ionic current passing around ssDNA within the nanopore is measured to provide detectable signals that correspond to characteristics of the ssDNA.
  • this current is influenced by multiple bases in MspA's narrow constriction zone.
  • Translocation of single stranded DNA (ssDNA) through MspA can be facilitated by a DNA polymerase (e.g., phi29) which draws the ssDNA through the nanopore in single nucleotide steps.
  • a DNA polymerase e.g., phi29
  • varying the voltage stretches the elastic ssDNA bases within MspA's constriction.
  • varying voltage was applied to an MspA nanopore system where ssDNA is translocated in single nucleotide steps by phi29. With the varying voltage, the changes in the current response were observed allowing measurement of position changes less than 100 pm. This position sensitivity is confirmed by comparing the present results to a modified freely jointed chain (FJC) model, an experimentally verified model that describes DNA elasticity (described above).
  • FJC freely jointed chain
  • Single stranded DNA is an inherently elastic molecule.
  • the end-to-end length of DNA can be altered by applying less than a pico Newton forces on the ends.
  • sequence-specific current-levels at different voltages were used to measure the changing position of ssDNA within the MspA.
  • the change in ssDNA position was compared to the standard model of DNA stretching.
  • Enzyme-assisted translocation of a nucleic acid through a nanopore can be advantageous to regulate the translocation rate. This can be essential to sufficiently slow the translocation of the nucleic acid to facilitate the detection of current signal fluctuations that are reflective of the specific sequence of the nucleic acid. Enzymes will move DNA through a nanopore in discrete steps to produce blockade events in the measured current that correspond to each discrete step movement. In contrast, the hypothetically slow but continuous movement of DNA through the nanopore can produce a continuous stream of measurable current corresponding to the passage of DNA at a much finer scale. This measurable current will provide a much higher scale of information regarding the structure of the DNA within the pore.
  • nanopores such as MspA have a constriction zone, which is the narrowest portion of the pore.
  • the segment of DNA in the constriction zone at any given time is the most influential portion of the DNA on the current of ions also passing through the pore.
  • FIGURE 14A illustrates the constriction zone (i.e., "DNA sensing zone") of a nanopore such as MspA, where the influence of the nucleotide position within the zone is indicated in the intensity of the shading.
  • the observed current expected DNA moving continuously through a nanopore would likely resemble a continuous curve, referred to as a continuous current profile (FIGURE 14B) and would reflect the continuously changing character (i.e., sequence) of the DNA segment within the constriction zone.
  • a molecular motor such as phi29 DNA polymerase, moves the DNA in single nucleotide steps, effectively "sampling" the current profile in 1 nt steps (FIGURE 14C). Any mechanism that repositions the DNA analyte within the nanopore constriction zone (FIGURE 14D) will result in a shift of the measured signal.
  • the continuous current profile is shifted (FIGURE 14E).
  • FIGURE 15A illustrates a plot of the value of observed currents observed current levels associated with seql for voltages of 160 mV and 180 mV. Comparing the sequence- specific currents a change in current pattern is observed. The change in the current pattern is explained by changing the position of ssDNA relative to MspA's constriction zone.
  • a custom "level" finder was employed to find changes in the I-V response.
  • a "level” refers to a discrete subset of current signals that are associated with a single translocation step of the ssDNA through the pore and, thus, the sequence of a discrete segment of the nucleic acid residing in the constriction zone at the time of the level.
  • This step in this case is facilitated by the molecular motor action of phi29 DNA polymerase.
  • This level finder is a modification to the level finder described in Laszlo et al., "Decoding long nanopore sequencing reads of natural DNA,” Nature Biotechnology 52:829-833 (2014), incorporated herein by reference in its entirety. See Methods section below for additional detail.
  • the continuously varied voltage was compared to the current observed within 1 mV of 180 mV and 160 mV. The observed currents observed for a continuously varying voltage are not distinguishable from currents observed at the different, constant voltages (not shown).
  • the sequence-specific currents observed at different voltages were used to measure the registration shift, such as a shift represented in FIGURE 16A.
  • L is the ssDNA contour length
  • b is the Kuhn length
  • k b is the Boltzmann constant
  • T is the temperature.
  • N(V) a/l ss +kT/(q V*b/a).
  • a phase shift between two voltages, VI and V2 is represented as a change in N, or:
  • the observed 5(V) was fit to the single-parameter equation [Eqn 9] demonstrating that the observations are well-described by the modified FJC model. This indicates that changing the electric force induces the registration shift is caused by elongating the ssDNA.
  • the sub-Angstrom position of nucleotides held within MspA's constriction were modified using variable force. Distance changes were detected on the order of 30 pm, and obtained a voltage-distance curve with 25 pm precision. This distance curve was fit to a model of ssDNA stretching, the FJC, with a single parameter. The accuracy to which this simple model described the observations confirms DNA stretching. It is observed that the change in position of the DNA sequence within the MspA constriction will change the current values by considerable shifts of 30 pm yield observable current differences on the order of 0.6 pA, with a current-distance sensitivity ration of 2 pA/A or higher. In these experiments, an increased force was used to change in the DNA position within the constriction.
  • DNA registration shift such as DNA secondary structure, DNA-pore interaction, DNA-enzyme interactions and other experimental conditions like temperature and buffer viscosity or salinity.
  • DNA secondary structure DNA-pore interaction
  • DNA-enzyme interactions DNA-enzyme interactions
  • other experimental conditions like temperature and buffer viscosity or salinity.
  • any registration shifts must be minimized or accounted for.
  • the present method enables a seemingly continuous "scan" of DNA as it moves through MspA.
  • the recreation of such a continuous scan can facilitate detection of any registration shifts, such as forward skips or backward toggles. Once detected, they can be addressed to infer any missing data.
  • Position changes of DNA can be detected within MspA that are on the order of 30 pm.
  • this expanded sensitivity of nanopores, such as MspA can be directly used as a high throughput single-molecule tool to detect sub-Angstrom characteristics of nucleic acid analytes.
  • Nanopore/translocation techniques were performed as generally described above and in Manrao, E.A., "Reading DNA at single-nucleotide resolution with a mutant MspA nanopore and phi29 DNA polymerase,” Nature Biotechnology 30:349-353 (2012), incorporated herein by reference in its entirety.
  • a single MspA pore was formed within in an unsupported phospholipid bilayer and used phi DNAP as a molecular motor to control the motion of DNA.
  • the DNA registration shift ⁇ were estimated. This was done in several steps. Initially the current at a given voltage was converted to the anticipated current at 180mV as described below. Next, for each step, the average current in 1 mV bins and for each sequential voltage bin was determined. Finally, the registration shift offset that would minimize the difference between a spline interpolant of the currents at one voltage was found, and the observed currents at the next (higher) voltage.
  • the non-ohmic resistance of the system was removed to transform an observed current at a given voltage, to the expected current at a constant voltage.
  • This current transformation emulates the current that would be found if the DNA nucleotides were positioned at the given location, while at a constant 180 mV using I-V measurements of homopolymer DNA (homopoly A, homopolyT and homopolyC) conjugated to a bulky NeutrAvidin-biotin.
  • the length of ssDNA i.e., number of nucleotide positions
  • the resolution of the system was minimized.
  • the resulting current signals measured at any given time represented a shorter combination of sequential nucleotide residues.
  • measured signals from homopolymers of different nucleotides were significantly more distinguishable, facilitating a simplified deconvolution process to associate any given current measurement with a specific nucleotides sequence.
  • MspA is a proteinaceous nanopore that has been successfully applied to systems for analysis of nucleic acid analytes.
  • MspA (30) generally has a conical shape with the entrance rim (40) creating the widest diameter of the internal tunnel of the nanopore.
  • the internal "vestibule" (50) possesses a conical shape where the diameter generally decreases along the axis when proceeding from the entrance rim towards the constriction zone (60).
  • the vestibule (50) is connected to the constriction zone (60) on the opposite end of the nanopore from the entrance rim (50), the constriction zone (60) generally providing the narrowest portion of the internal tunnel of the MspA nanopore (30). It is the segment of the ssDNA residing in the constriction zone (60) at any given moment that influences the ionic current passing through the pore, and thus determines the measurable signal in the system.
  • the forward orientation for MspA was previously preferred because the typical methodologies for forming and embedding MspA in a lipid bilayer membrane resulted in a vast majority (around 80%) of MspA nanopores inserting into the membrane in the forward orientation.
  • such methodologies generally followed the methodology described in Butler, T.Z., et al, Proc. Natl. Acad. Sci. USA 105:20647- 20652 (2008), where lipid bilayers were formed across a horizontal ⁇ 20 ⁇ diameter Teflon aperture with the ⁇ 60 ⁇ compartments on both sides of the bilayer contained experimental buffer.
  • An Axopatch 200B integrating patch clamp amplifier (Axon Instruments) applied a 180 mV voltage across the bilayer (trans side positive) and measured any current.
  • the MspA monomers were added to the grounded cis compartment to yield a concentration of ⁇ 2.5 ng/ml. Once a single pore inserted, the compartment was flushed with experimental buffer to avoid further insertions.
  • the forward orientation for MspA was previously preferred because when MspA nanopores inserted into the bilayer membrane in the "reverse" orientation, i.e., with the constriction zone more proximate to the cis compartment and the vestibule and entrance rim more proximate to the trans compartment (see FIGURE 23, right diagram), the nanopore exhibited significant gating, or spontaneous changes of conductance that would be difficult to distinguish from current events associated with an analyte. Gating typically increases in proteinaceous nanopores with increasing voltages and results in a decrease the conductivity of the nanopore. This trend was observed to be especially pronounced for MspA in the reverse orientation.
  • the frequency of non-analyte gating increased.
  • the most drastic transition was observed between applications of 80 mV and 100 mV, although the frequency and severity of the gating events continued to increase past an applied potential of 140 mV (not shown).
  • Such a tendency to gate is typically a disfavored characteristic for such nanopores because it possibly reflects aberrations in the structure of the nanopore and suggests inconsistent passage of analytes or ions through the pore, decreasing its utility for sequencing.
  • the gating signals are often difficult to distinguish from true conductance events associated with a nucleic acid analyte.
  • MspA nanopores inserting into the bilayer membranes in the reverse orientation were typically discarded for purposes of ssDNA analysis.
  • the present study surprisingly found that MspA nanopores 1) could be stably formed in a bilayer membrane with increasing frequency and 2) could function thereafter without the gating problems previously observed and provide an additional benefit of reduced Brownian Motion in the nucleic acid, leading to a more clearly resolved current signal.
  • FIGURE 24 illustrates the current (I) to voltage (V) relationship for a backward (i.e., reverse orientation) pore and two forward orientation pores.
  • Both of the forward pores had a similar current to voltage relationship and the backward pore had a distinct current to voltage relationship, thus enabling the identification of the pore orientation within a membrane. Furthermore, when the electrode poles and applied voltage were reversed on the forward pores revealed that the resulting current to voltage relationship was nearly indistinguishable with the relationship previously observed for the backwards pore. See FIGURE 24, dashed lines. Thus, reverse orientation of MspA can be confirmed by the observed current to voltage relationship resulting therefrom.
  • FIGURE 23 illustrates MspA nanopores in the reverse orientation
  • ssDNA analyte was introduced into the cis compartment of the nanopore system.
  • the ssDNA was associated with phi29 DNA polymerase to provide a molecular brake to the ssDNA and regulate its translocation rate through the nanopore in single nucleotide steps.
  • FIGURES 25A and 25B illustrate a comparison between the non-analyte gating of the reverse nanopore (FIGURE 25 A) and nucleic acid-associated current events observed with the same reverse nanopore (FIGURE 25B).
  • the MspA in a reverse orientation permits a much reduced distance between the constriction zone of the MspA and the molecular brake that regulates the translocation of the linear nucleic acid through the pore.
  • This reduced distance (see, e.g., the comparison in FIGURE 23) is believed to result in a reduced Brownian motion of the nucleic acid within the constriction zone region.
  • the reduction of Brownian motion minimizes the effective nucleic segment length that influences the observed current flow and, thus, simplifies the association between the observed current levels and the structure of the corresponding segment of the nucleic acid. This is supported by various analyses.
  • the averaging effect in a reverse pore results from a shorter sequence of nucleotides of the nucleic acid, and fewer nucleotides determine the measured current signal.
  • the width of the effective constriction zone is modeled using the observed levels and aligning to the actual sequence of the nucleic acid, as illustrated in FIGURE 26B. See also Laszlo et al., “Decoding long nanopore sequencing reads of natural DNA,” Nature Biotechnology 52:829-833 (2014), incorporated herein by reference in its entirety).
  • the effective width (i.e., phase) of the reverse nanopore is narrower than in the forward pore, indicating that fewer nucleotides contribute to the observed current signals when the MspA is in the reverse orientation.
  • FIGURE 26C illustrates a comparison of the frequency of different current readings observed for the same nucleic acid using MspA nanopores in the reverse and forward orientations.
  • the MspA nanopore in reverse orientation produces current levels that span a wider range of currents, with a much higher frequency of currents in the high and low end of the measured currents.
  • the forward pore exhibits more typical bell-curve of recorded current distribution, such that currents corresponding to distinct nucleic acid subsequences are more likely to overlap in range of current produced.
  • MspA nanopore can be inserted in a bilayer membrane of the system in a reverse orientation and still provide useful current signal without an increase in gating frequency. Furthermore, the nanopore system with the MspA nanopore in the reverse orientation minimizes the influence of Brownian motion of the ssDNA analyte, thus generating a signal with higher resolution that reflects a shorter sequence of nucleotides in the constriction zone and provides an enhanced signal differentiation between the distinct nucleotide species in the ssDNA.

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Nanotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

La présente invention concerne généralement le domaine des analyses fondées sur des nanopores de polymères, tels que des polymères d'ARN et d'ADN. Selon un aspect, la présente invention porte sur des procédés d'analyse d'un acide nucléique, dans un système fondé sur des nanopores, qui comprennent une application de potentiels électriques non constants à mesure que l'acide nucléique subit une translocation à travers le nanopore. Les procédés facilitent la réalisation de profils de courant continu informatifs pour évaluer des caractéristiques de l'analyte d'acide nucléique. Selon un autre aspect, la présente invention porte sur des systèmes et sur des procédés de réduction de mouvement brownien d'analytes d'acide nucléique dans des nanopores pour fournir une résolution améliorée d'analyses fondées sur des nanopores.
PCT/US2014/059360 2013-10-04 2014-10-06 Systèmes et procédés pour analyse fondée sur des nanopores d'acides nucléiques WO2015051378A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361887236P 2013-10-04 2013-10-04
US61/887,236 2013-10-04
US201461941900P 2014-02-19 2014-02-19
US61/941,900 2014-02-19

Publications (1)

Publication Number Publication Date
WO2015051378A1 true WO2015051378A1 (fr) 2015-04-09

Family

ID=52779229

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/059360 WO2015051378A1 (fr) 2013-10-04 2014-10-06 Systèmes et procédés pour analyse fondée sur des nanopores d'acides nucléiques

Country Status (1)

Country Link
WO (1) WO2015051378A1 (fr)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017098322A1 (fr) * 2015-12-08 2017-06-15 Katholieke Universiteit Leuven Ku Leuven Research & Development Nanopores modifiés, compositions les comprenant et leurs utilisations
WO2017125565A1 (fr) * 2016-01-21 2017-07-27 Genia Technologies, Inc. Complexes de séquençage par nanopores
US10359395B2 (en) 2014-02-19 2019-07-23 University Of Washington Nanopore-based analysis of protein characteristics
WO2020043082A1 (fr) * 2018-08-28 2020-03-05 Nanjing University Nanopore protéique pour l'identification d'un analyte
US10844432B2 (en) 2014-05-02 2020-11-24 Oxford Nanopore Technologies, Ltd. Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
US10882889B2 (en) 2012-04-10 2021-01-05 Oxford Nanopore Technologies Ltd. Mutant lysenin pores
US10975428B2 (en) 2016-03-02 2021-04-13 Oxford Nanopore Technologies Ltd. Mutant pore
US10976311B2 (en) 2013-03-25 2021-04-13 Katholieke Universiteit Leuven Nanopore biosensors for detection of proteins and nucleic acids
WO2021111125A1 (fr) * 2019-12-02 2021-06-10 Oxford Nanopore Technologies Limited Procédé de caractérisation d'un polypeptide cible à l'aide d'un nanopore
US11034734B2 (en) 2014-09-01 2021-06-15 Oxford Nanopore Technologies Ltd. Mutant pores
CN113322180A (zh) * 2021-05-31 2021-08-31 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
US11104709B2 (en) 2016-04-06 2021-08-31 Oxford Nanopore Technologies Ltd. Mutant pore
US11169138B2 (en) 2015-04-14 2021-11-09 Katholieke Universiteit Leuven Nanopores with internal protein adaptors
US11307192B2 (en) 2015-02-19 2022-04-19 Oxford Nanopore Technologies Plc Method for producing a hetero-oligomeric pore comprising two different monomers in a specific stiochiometric ratio
US11572387B2 (en) 2017-06-30 2023-02-07 Vib Vzw Protein pores
WO2023030146A1 (fr) * 2021-08-30 2023-03-09 四川大学 Méthode d'analyse de compositions de polypeptides basées sur des nanopores à mspa modifiés par des ions cuivre
CN115877018A (zh) * 2022-08-05 2023-03-31 四川大学华西医院 一种孔蛋白在制备检测去氢表雄酮硫酸酯的试剂盒中的应用
CN116179663A (zh) * 2023-01-30 2023-05-30 天津大学 一种基于γ-溶血素纳米孔道收缩区实现核酸单分子片段式测序的方法
US11725235B2 (en) 2014-01-22 2023-08-15 Oxford Nanopore Technologies Plc Method for attaching one or more polynucleotide binding proteins to a target polynucleotide

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625706B2 (en) * 2004-03-23 2009-12-01 Agilent Technologies, Inc. Methods and apparatus for characterizing polynucleotides
WO2010086603A1 (fr) * 2009-01-30 2010-08-05 Oxford Nanopore Technologies Limited Enzyme mutante
US20120055792A1 (en) * 2008-09-22 2012-03-08 The Uab Research Foundation Msp nanopores and related methods
WO2013016486A1 (fr) * 2011-07-27 2013-01-31 The Board Of Trustees Of The University Of Illinois Capteurs à nanopore pour la caractérisation biomoléculaire
US20130146457A1 (en) * 2010-02-23 2013-06-13 University Of Washington Analyte sequencing with nanopores

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625706B2 (en) * 2004-03-23 2009-12-01 Agilent Technologies, Inc. Methods and apparatus for characterizing polynucleotides
US20120055792A1 (en) * 2008-09-22 2012-03-08 The Uab Research Foundation Msp nanopores and related methods
WO2010086603A1 (fr) * 2009-01-30 2010-08-05 Oxford Nanopore Technologies Limited Enzyme mutante
US20130146457A1 (en) * 2010-02-23 2013-06-13 University Of Washington Analyte sequencing with nanopores
WO2013016486A1 (fr) * 2011-07-27 2013-01-31 The Board Of Trustees Of The University Of Illinois Capteurs à nanopore pour la caractérisation biomoléculaire

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11845780B2 (en) 2012-04-10 2023-12-19 Oxford Nanopore Technologies Plc Mutant lysenin pores
US10882889B2 (en) 2012-04-10 2021-01-05 Oxford Nanopore Technologies Ltd. Mutant lysenin pores
US10976311B2 (en) 2013-03-25 2021-04-13 Katholieke Universiteit Leuven Nanopore biosensors for detection of proteins and nucleic acids
US11761956B2 (en) 2013-03-25 2023-09-19 Katholieke Universiteit Leuven Nanopore biosensors for detection of proteins and nucleic acids
US11725235B2 (en) 2014-01-22 2023-08-15 Oxford Nanopore Technologies Plc Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
US12085533B2 (en) 2014-02-19 2024-09-10 University Of Washington Nanopore-based analysis of protein characteristics
US11808734B2 (en) 2014-02-19 2023-11-07 University Of Washington Nanopore-based analysis of protein characteristics
US10359395B2 (en) 2014-02-19 2019-07-23 University Of Washington Nanopore-based analysis of protein characteristics
US10948454B2 (en) 2014-02-19 2021-03-16 University Of Washington Nanopore-based analysis of protein characteristics
US11739377B2 (en) 2014-05-02 2023-08-29 Oxford Nanopore Technologies Plc Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
US10844432B2 (en) 2014-05-02 2020-11-24 Oxford Nanopore Technologies, Ltd. Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
US11034734B2 (en) 2014-09-01 2021-06-15 Oxford Nanopore Technologies Ltd. Mutant pores
US11307192B2 (en) 2015-02-19 2022-04-19 Oxford Nanopore Technologies Plc Method for producing a hetero-oligomeric pore comprising two different monomers in a specific stiochiometric ratio
US11169138B2 (en) 2015-04-14 2021-11-09 Katholieke Universiteit Leuven Nanopores with internal protein adaptors
US10976300B2 (en) 2015-12-08 2021-04-13 Katholieke Universiteit Leuven Modified nanopores, compositions comprising the same, and uses thereof
CN109072295A (zh) * 2015-12-08 2018-12-21 鲁汶大学研究与发展中心 修饰的纳米孔,包含其的组合物及其应用
JP2019507583A (ja) * 2015-12-08 2019-03-22 カトリック ユニヴェルシテット ルーヴェン カーユー ルーヴェン リサーチ アンド ディベロップメント 修飾ナノポア、それを含む組成物およびその使用
WO2017098322A1 (fr) * 2015-12-08 2017-06-15 Katholieke Universiteit Leuven Ku Leuven Research & Development Nanopores modifiés, compositions les comprenant et leurs utilisations
CN109072295B (zh) * 2015-12-08 2022-05-31 鲁汶大学研究与发展中心 修饰的纳米孔，包含其的组合物及其应用
JP2022046503A (ja) * 2015-12-08 2022-03-23 カトリック ユニヴェルシテット ルーヴェン カーユー ルーヴェン リサーチ アンド ディベロップメント 修飾ナノポア、それを含む組成物およびその使用
WO2017125565A1 (fr) * 2016-01-21 2017-07-27 Genia Technologies, Inc. Complexes de séquençage par nanopores
US11685949B2 (en) 2016-03-02 2023-06-27 Oxford Nanopore Technologies Plc Mutant pore
US12018326B2 (en) 2016-03-02 2024-06-25 Oxford Nanopore Technologies Plc Mutant pore
US11597970B2 (en) 2016-03-02 2023-03-07 Oxford Nanopore Technologies Plc Mutant pores
US10975428B2 (en) 2016-03-02 2021-04-13 Oxford Nanopore Technologies Ltd. Mutant pore
US11186868B2 (en) 2016-03-02 2021-11-30 Oxford Nanopore Technologies Plc Mutant pore
US10995372B2 (en) 2016-03-02 2021-05-04 Oxford Nanopore Technologies Ltd. Mutant pores
US11939359B2 (en) 2016-04-06 2024-03-26 Oxford Nanopore Technologies Plc Mutant pore
US11104709B2 (en) 2016-04-06 2021-08-31 Oxford Nanopore Technologies Ltd. Mutant pore
US12084477B2 (en) 2017-06-30 2024-09-10 Vib Vzw Protein pores
US11572387B2 (en) 2017-06-30 2023-02-07 Vib Vzw Protein pores
US11945840B2 (en) 2017-06-30 2024-04-02 Vib Vzw Protein pores
WO2020043082A1 (fr) * 2018-08-28 2020-03-05 Nanjing University Nanopore protéique pour l'identification d'un analyte
CN118011004A (zh) * 2019-12-02 2024-05-10 牛津纳米孔科技公开有限公司 使用纳米孔表征靶多肽的方法
EP4270008A3 (fr) * 2019-12-02 2024-01-10 Oxford Nanopore Technologies PLC Procédé de caractérisation d'un polypeptide cible à l'aide d'un nanopore
WO2021111125A1 (fr) * 2019-12-02 2021-06-10 Oxford Nanopore Technologies Limited Procédé de caractérisation d'un polypeptide cible à l'aide d'un nanopore
CN113322180A (zh) * 2021-05-31 2021-08-31 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
CN113322180B (zh) * 2021-05-31 2022-07-15 中国科学院物理研究所 基于纳米孔测序的力谱分析方法和分析装置
WO2023030146A1 (fr) * 2021-08-30 2023-03-09 四川大学 Méthode d'analyse de compositions de polypeptides basées sur des nanopores à mspa modifiés par des ions cuivre
CN115877018A (zh) * 2022-08-05 2023-03-31 四川大学华西医院 一种孔蛋白在制备检测去氢表雄酮硫酸酯的试剂盒中的应用
CN116179663B (zh) * 2023-01-30 2023-12-22 天津大学 一种基于γ-溶血素纳米孔道收缩区实现核酸单分子片段式测序的方法
CN116179663A (zh) * 2023-01-30 2023-05-30 天津大学 一种基于γ-溶血素纳米孔道收缩区实现核酸单分子片段式测序的方法

Similar Documents

Publication Publication Date Title
WO2015051378A1 (fr) Systèmes et procédés pour analyse fondée sur des nanopores d'acides nucléiques
US12085533B2 (en) Nanopore-based analysis of protein characteristics
US11401549B2 (en) Analysis of a polymer
US20210032695A1 (en) Selective modification of polymer subunits to improve nanopore-based analysis
Laszlo et al. MspA nanopore as a single-molecule tool: From sequencing to SPRNT
Purnell et al. Discrimination of single base substitutions in a DNA strand immobilized in a biological nanopore
Timp et al. Nanopore sequencing: electrical measurements of the code of life
Ma et al. Biological nanopores for single-molecule biophysics
CN103328973B (zh) 双孔装置
US11994508B2 (en) Method and system for linearization and translocation of single protein molecules through nanopores
Mereuta et al. Considerable slowdown of short DNA fragment translocation across a protein nanopore using pH-induced generation of enthalpic traps inside the permeation pathway
WO2024156993A1 (fr) Étalonnage d'un dispositif de réseau de nanopores
Sowerby et al. A proposition for single molecule DNA sequencing through a nanopore entropic trap
Purnell The interpretation of ionic currents produced by controlled DNA translocation through the alpha-hemolysin nanopore

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14850181

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14850181

Country of ref document: EP

Kind code of ref document: A1